Lipid Matters

Subscribe to Lipid Matters Blog

You need an RSS Feed Reader to subscribe.

20 July 2026

New Target for Treating Barth Syndrome: ABHD18

The remodeling of nascent cardiolipin (nCL) involves its diacylation to remove saturated fatty acids, followed by its reacylation with polyunsaturated fatty acids generating mature cardiolipin (CL). The diacylation is catalyzed by an enzyme known as ABHD18 (alpha-beta hydrolase domain 18) leading to monolysocardiolipin (MLCL) while the reacylation is catalyzed by an enzyme known as Tafazzin (TAZ). This remodeling is essential to establish the proper membrane curvature, and stabilization of proteins involved in the electron transport chain. Defects in this remodeling lead to metabolic defects, with Barth Syndrome receiving much of the attention. This syndrome is caused by a genetic mutation in the Tafazzin gene. Much of the past research into treatments of Barth Syndrome have focused on symptom management. I recently found a paper I had missed as it was published in September of 2025 by Masud et al. This paper suggests a potentially powerful approach to this disease may be to inhibit the ABHD18 deacylating enzyme. The authors show that preventing or reducing ABHD18 activity, even with small molecule inhibitors, compensates for TAZ deficiency. This may be a new and powerful approach to treating Barth Syndrome.

Dan M. Raben

The John Hopkins University School of Medicine, Baltimore, MD, USA

---

6 July 2026

Mapping lipid cargo across the human lipid transfer proteome

A systematic map of which lipids are carried by which lipid transfer proteins (LTPs) was published earlier this year by Titeca et al.. The study analyzed hundreds of human LTPs for their lipid cargo and validated the hits functionally: if a transporter moves a specific lipid, overexpressing it should perturb the metabolic flux and steady-state equilibrium of that lipid, thereby measurably shifting the total cellular lipid composition. This closed-loop logic -screening, followed by functional perturbation via gain-of-function experiments, and finally measuring the resulting changes in the whole-cell lipidome - is what gives the dataset credibility beyond a simple binding catalogue.

With this large amount of data, the researchers were able to discover general rules about how LTPs transport lipids. Rather than acting as highly specific, single-cargo machines, most LTPs seem to interact with multiple lipid classes simultaneously. Beyond headgroup recognition, acyl chain properties often play a consistent role, particularly for glycerophospholipids, where LTPs frequently mobilize species with shorter fatty acids and one or two degrees of unsaturation, likely because these are easier to extract from membrane bilayers. However, this may not be a universal rule.

These nuanced binding preferences are key to understanding the LTP network as a whole. The dataset provides a systematic characterization of LTP-lipid complexes, revealing functional relevance for both known and newly identified ligands. How cells orchestrate directional lipid flow across dozens of transporters simultaneously is a question the field can now begin to ask in a much more systematic way, and this resource provides a solid foundation to do so.

Olya Vvedenskaya, MD, PhD

Lipotype

---

22 June 2026

Eigenlipids

This blog will be a bit different from most. Why? Because a colleague of mine recently sent me a review (Sing et al. J Lipid Res. 2026, online ahead of print) of an approach in lipidomic analyses that I must admit I hadn’t heard of: Eigenlipids. The approach is derived from an approach first used and popularized in transcriptomics. Eigenlipids may turn out to be an important tool for the analyses of lipids observed in lipidomic studies but there are, however, some drawbacks. Eignelipids derive their name from eigenvectors and eigen values and represent clusters of lipids, termed modules. In general, highly correlated lipids are separated into clusters or "modules". Each module is subjected to principal component analyses (PCA) and the resulting principal components are ordered according to the fraction of a total variance, and the first principal component is designated as the "eigenlipid" for that entire module of lipids. The review, introduces eigenlipids, their construction and use to examine lipid metabolism in biological systems. It also highlights current limitations and presents new potential strategies for eigenlipid generation. It’s not clear how useful this will actually be in a final analysis, but it is something that will likely be discussed further in the near future.

Dan M. Raben

The John Hopkins University School of Medicine, Baltimore, MD, USA

---

8 June 2026

Evidence for a new phospholipid class generated in bacteria from condensation of PI and PA.

The discovery of lipid molecular species continues to be a hot topic, with huge interest in microbial lipidomes leading to regular identification of new compounds from across the range of LIPID MAPS lipid categories. Relating to this, a paper from Abreu et al. claiming to identify a new category of phospholipids, based on condensation of two well-known PLs (PI and PA) was published recently in the Journal of Natural Products. It’s interesting to review this as it provides an opportunity for us to consider…what evidence do we need to be able to claim a new structure, and if we don’t have enough, how do we ensure that we communicate the right level of caution to readers?

Even if the structure is not fully elucidated, providing the evidence with a description of a “proposed” structure, and including statements about what additional evidence would be required is important, since this will stimulate others to follow and refine the structure as needed. But what we always need to be careful of is not overclaiming, e.g. not claiming structural features such as stereochemistry or functional group position where it’s not proven.

In this study, a new class called PIPA (phosphatidylinositol–phosphatidic acid) were proposed to be present in Streptomyces strains, with the evidence being obtained from normal phase chromatography coupled to high resolution mass spectrometry. The first pitfall that researchers can fall into relates to not using chromatography to separate lipids, where in source adducts form that masquerade as actual molecular species…. This issue doesn’t apply to this paper, where NPLC was used, and it was shown that the lipids elute between cardiolipin and PI. This confirms they are discrete molecular species. They elute far later than glycerides but right in the middle of the PL categories as expected for the proposed structures. Another question is whether they could form chemically during lipid extraction, e.g. if non-standard or harsh conditions were used. In this study the process was a straightforward Bligh and Dyer extraction, making this unlikely.

The MS data presented shows a large cluster of molecular species in negative ion mode from around m/z 1397-1453. One of these lipids, proposed as 15:0_16:0 containing PI and PA condensed at the phosphates was selected for MS2 and MS3, and data broadly agrees with the fragmentation proposed, namely: loss of DG 16:0_15:0, a headgroup ion consisting of inositol and 2 phosphates, and several other ions consistent with FA losses or the FA carboxylate ions for 15:0 or 16:0. The presence of inositol was suggested based on lack of reactivity of the lipid with compounds that would indicate hexoses instead. However, lack of evidence isn’t quite the same as evidence, and a second issue with the study is the complete lack of any synthetic standards with which to confirm retention times or fragmentation patterns. As with all of these types of studies, when dealing with complex biological mixtures, purification of material for NMR was presumably not feasible.

How confident can we be of this new PL category? The authors state that while the chemical structure suggests a condensation between PI and PA, it doesn’t allow any conclusion to be drawn regarding biosynthesis. While this is true, it was also stated in the paper that “a detailed methodological framework is presented in this study, allowing for the characterization of different lipid classes and the discovery of a novel class of lipids called PIPA.” The question to ask is…is MS data in the absence of a synthetic standard or NMR, evidence enough to claim a structure? History tells us to be cautious and that this should be evidence to propose a structure, but we should be clear that further evidence, such as direct comparison with a standard is required to substantiate this assertion. It will be interesting to see further work on this new and interesting PL class as it emerges.

Valerie O’Donnell

Cardiff University

---

26 May 2026

A Chloride Channel-like Protein Assists in Lipoprotein Biogenesis and Nuclear Pore Formation

I’m often surprised when I see evidence for a protein-protein interaction that I would have never suspected. Such is the case for two recent papers that described the interaction of endoplasmic reticulum-localized anion channel, CLCCL1 (chloride channel CLIC-like1), and a lipid scramblase TMEM41b.Using cryo-electron tomography (cryo-ET) coupled with high-pressure cryo-fixation (HPF), the Wu lab showed that association of CLCC1 with the TMEM41b is required for normal formation of lipid droplets (Nature 652, pages471–480 (2026)). The notion is that CLCC1 assists in modulating the trans-bilayer equilibration of phospholipids. It’s interaction with TMEM41B promotes lipid scrambling leading to lipoprotein biogenesis. A companion paper from the Olzmann lab (Nature 652, 462–470 (2026)) takes a more genetic approach involving CRISPR-Cas9 screens and notes that CLCC1 is structurally similar to yeast Br1 and Br6 proteins involved in NPC formation. They provide evidence that the loss of CLCC1 also reduces the number of nuclear pores. Taken together, these studies show the importance of the interaction of both CLCC 1 with TMEM41b in both lipoprotein and nuclear pore biogenesis.

Dan M. Raben

The John Hopkins University School of Medicine, Baltimore, MD, USA

---

8 May 2026

A new role for ATG2A: moving neutral lipids, not just phospholipids.

Bridge-like lipid transfer proteins (BLTPs) have long been known to facilitate bulk movement of phospholipids across membrane contact sites. Through this, they allow trafficking of lipids between different bilayer membranes, for example during autophagy when source membrane lipids are directed to autophagosome precursor membranes.

In contrast, up to now, processes that support movement of neutral lipids between organelles have not been identified, for example triglycerides (TGs) contained in lipid droplets (LDs). Here a key difference is that the membrane is a monolayer, not a bilayer, and so the microenvironment will be very different to that of all other cell membranes. Highlighting this, transmembrane proteins can’t bind/insert into the surface of LDs.

Addressing this question, a recent paper in Proceedings of the National Academy of Sciences has demonstrated that the BLTP member, ATG2A, well known for its roles in driving autophagy (where it moves lipids from the ER to the phagophore), may have a far wider role in lipid metabolism. Just to give some context to this protein and its importance, the roles of ATG2 (A and B) in autophagy were identified in the lab of Yoshinori Ohsumi and colleagues in Tokyo and contributed directly to the awarding of the Nobel Prize in Medicine or Physiology in 2016 for discovery of molecular processes of autophagy.

In this new study, Korfhage et al found that ATG2A, which is known to be associated with LD, can also transport TGs between organelles.This indicates it also acts as a neutral lipid transfer protein. In some ways, it wasn’t entirely surprising considering that it’s long been known to be located on LDs, however that it can also work on lipid monolayers considering the biophysical constraints is intriguing.

Here, using synthetic membrane systems and lipidomics of purified ATG2A, the team showed that the protein binds especially well to LD monolayers, where it transfers lipids efficiently. Surprisingly, TG movement had similar kinetics to phospholipid transport, indicating ATG2A can traffic both structural membrane lipids as well as those involved in energy storage.

Why does this matter? LDs are increasingly recognized as being multifunctional dynamic organelles that play essential roles in diverse functions including energy balance, membrane homeostasis, and inflammatory/stress responses. This new study suggests ATG2A may also support lipid exchange between LDs and other organelles, linking autophagy with many other functions. Through this, it suggests a potential involvement of BLTPs as regulators of whole-cell lipid biochemistry.

Intriguingly, such a widening of the functions of BLTPs suggests a far broader functions in maintaining human health and disease. So far, mutations in ATG2A (or B) are not known in human disease, suggesting that they may be embryonically lethal. A few reports link ATG2 variants to disease phenotype but this is not widely studied or validated as yet. If ATG2A is a TG transfer protein, we may expect to see an impact on hepatic steatosis, atherosclerosis, brown fat thermogenesis, lipotoxicity and other metabolic conditions but that’s for future study.

Open access version is here

Disclaimer: ChatGPT kindly helped with research on this topic, and summarizing of the article, but all facts were checked.

Valerie O’Donnell, Cardiff University

---

14 April 2026

Another Role for PtdIns(3,5)P_2:In Immune Signaling

Foreign, or even misplaced DNA, in the cytosol trigger innate immune signaling that involves the induction of Type I interferon and proinflammatory cytokines. This is important as it participates in the defense of pathogens and clearance of damaged cells. A major pathway implicated in this response is termed the cGAS-STING (cyclic GMP–AMP synthase–stimulator of interferon genes).While this is a well-studied system, a new report by Tan et al. provides intriguing evidence for a PtdIns(3,5)P₂ role in this signaling system. Specifically, the authors show that PtdIns(3,5)P₂ binds directly to STING and promotes cGAMP-induced oligomerization. Depletion or mutation of PIKFYVE, the enzyme responsible for producing PtdIns(3,5)P₂ in mammalian cells, or mutation of the PtdIns(3,5)P₂-binding residues in STING suppresses its signaling. These findings reveal another role for PtdIns(3,5)P₂ in innate immunity.

Dan M. Raben

The John Hopkins University School of Medicine, Baltimore, MD, USA

---

31 March 2026

Structures of a lipin/Pah phosphatidic acid phosphatase

The conversion of phosphatidic acid (PtdOH) to diacylglycerol is important for triacylglycerol synthesis as well serving to convert one signaling molecule (PtdOH) into another (DAG). Lin/Pah phosphatidic acid phosphatases (PAPs) are important Mg⁺²-dependent enzymes that catalyze this conversion. Indeed, deficiencies in PAP activity has been associated with inflammatory disorders in humans. Despite the importance of these enzymes, there has been interest in understanding their structure and regulation. In December of 2025, the Airola lab published high resolution (1.95–2.40 Å) structures of a PAP in Tetrahymena thermophila Pah2. Their data resolve active and inactive states involved in catalysis. In addition to the active and inactive states, the data highlight the role of two highly conserved aspartate and arginine residues in coordinating with Mg⁺² and are involved in the recognition of PtdOH. The data provide some new and critical structural insights involved in catalysis and defines an important Asp-Arg motif in lipin/Pah PAPs. These data will certainly lead to more mechanistic insight into the catalytic chemistry of these enzymes.

Valerie O’Donnell,

Cardiff University

---

31 March 2026

Opening the window to unusual PL and how they are made.

When it comes to phospholipids (PL), the most abundant species are asymmetric, with generally a saturated fatty acid (FA) attached at sn-1, and an unsaturated (e.g. PUFA) at sn-2. As lipidomics technologies have advanced in recent years, methods such as ion mobility spectrometry (IMS) and enhanced fragmentation (e.g. ozone-induced dissociation) have allowed profiling of the exact positions of individual FA in PL. These revealed that species that don’t follow this rule exist as minor components, where a PUFA is instead found at sn-1. Very little is known about these “atypical” PL, for example how they are made, and also, why. Whether they have functions independent of the more abundant species is totally unknown. The formation of asymmetric PL is considered to be determined by Lands’ cycle remodelling, the process by which saturated FA-containing PL are hydrolyzed, then reacylated by lysophospholipid acyltransferases (LPLATs) working in concert with fatty acyl-CoA synthetases (ACSLs). Lands’ cycle was originally discovered in the 1950’s and is still considered the key process generating classic tissue PL signatures through remodelling largely saturated PL species to asymmetric that contain PUFA at sn-2. But what about sn-1?

LPLATs exist as 14 separate proteins, with varying substrate specificities, some preferring longer chain FA or arachidonate (AA) while others are involved in generation of phosphatidyl acid (PA) rather than PL. Most of what is known concerns remodelling at sn-2, while the remodelling at sn-1 is less characterized. One reason for this has been technical.LysoPL with the FA at sn-2 are not stable, with rapid migration of the FA to sn-1 happening under physiological conditions. In this study, being able to prevent acyl migration using acidic conditions has enabled Kawana et al in a recent study published in the Journal of Lipid Research to begin to study the process of sn-1 remodelling through the preparation of large amounts of lysoPL substrate with the FA at sn-2 instead. Using this and LPLAT knockout mice, they were able to identify that the isoform Lplat10 (in mice) was responsible for acylation of unsaturated FA including oleic, linoleic, AA and DHA into sn-1 of LPC, LPE and LPS as acyl acceptors but not LPI, LPG or LPA. LPLAT10 was highly expressed in neurons, while brain tissue lacking it showed significantly different PL composition, consistent with its proposed role in remodelling.

This study stands out for various reasons. New generation profiling methods such as IMS and enhanced fragmentation have become increasingly popular with many researchers using them to find new lipids. While generally these are less abundant, this doesn’t make them less interesting. In fact, history tells us that low abundance lipids can often be extremely important, for example through mediating receptor-dependent signaling processes. Moving beyond the discovery of these unusual PL species, Kawana et al started to unravel the underpinning biochemistry. The fact that these PL come from a biosynthetic pathway that is regulated and tissue specific suggests a defined biological role. Although mice lacking LPLAT10 did not show any obvious defects, how they respond to disease challenge has not yet been tested. Future studies on these mice may help reveal why mammals make these unusual lipids and whether this links to human disease.

Valerie O’Donnell

Cardiff University

---

16 March 2026

Prescription Medicines and Cholesterol Biosynthesis

Cholesterol is an essential structural molecule, it is a regulator of its own synthesis via convergent inhibition, and a precursor a myriad of signalling molecules. Cholesterol is particularly important in the CNS which contains about one quarter of the cholesterol found in the whole body. In all mammals, the majority of growth and differentiation of the CNS occurs during the late stages of embryonic development and early after birth, when all cholesterol in the CNS comes from de novo synthesis. Inherited metabolic deficiencies in enzymes of post-lanosterol cholesterol biosynthesis, such as in 7-dehydrocholesterol reductase (DHCR7), which leads to Smith-Lemli-Opitz syndrome (SLOS), are often characterised by complex neurodevelopmental problems and dysmorphologies and this has led to an increased interest in prescription medicines which inhibit DHCR7, particularly during pregnancy.

The effects of prescription medicines on enzymes of post-lanosterol pathways were reported by Hall et al in 2013 who found, by examining medical histories, that aripiprazole, an antipsychotic medication, and trazodone, an antidepressant, resulted in elevated concentrations of 7-dehydrocholesterol (7-DHC). These medications were later shown to inhibit DHCR7 explaining the elevation of 7-DHC. More recent work by Korade, Porter and colleagues has found evidence for more than 30 medications disrupting post-lanosterol sterol biosynthesis. Of these, Tallman et al now report in detail on how 11 selected medications disrupt cholesterol biosynthesis pathways. Each medication was tested on human dermal fibroblasts and 13 post-lanosterol metabolites measured by quantitative LC-MS/MS. By measuring substrates and products of the enzymes in the pathways the exact effect of each medication on the pathways was evaluated. Many of the medications were shown to inhibit DHCR7 including cariprazine, an antipsychotic, nebivolol, an antihypertensive, and rotigotine, used in the treatment of Parkinson’s disease, depression and restless leg syndrome, importantly, the concentrations of 7-DHC approached levels seen in SLOS fibroblasts. Other medications had duel effects on enzymes of the pathways. Buspirone, an antidepressant, and lurasidone, an antipsychotic, inhibit DHCR7 and dehydrocholesterol reductase 14 (DHCR14); amiodarone, used to treat irregular heartbeats, inhibits both desmosterol reductase (DHCR24), inherited deficiency of which leads to desmosterolosis, a disorder which like SLOS presents with dysmorphology, and 3β-hydroxysteroid-Delta(8),Delta(7)-isomerase, genetic deficiency of which leads to MEND (Male EBP disorder with neurologic defects) and CDPX2 (X-linked dominant chondrodysplasia punctata-2); while vilazodone, used to treat depression, and ziprasidone, an antipsychotic, both inhibit DHCR7, DHCR14 and DHCR24.

The significance of this study by Tallman et al is that many of these medications are routinely prescribed to pregnant women and sterol biosynthesis is critical during intrauterine and early postnatal life. This is an important area of future research as exact mechanisms of sterol inhibition have yet to be uncovered and the ultimate effects on human health will be dose dependent and the problem of polypharmacy still needs to be considered.

Yuqin Wang and William Griffiths

Swansea University

---

12 March 2026

Beef lipidomics and health implications

A 2025 lipidomic analysis by Elliott and colleagues characterized the distinct lipid profiles of lean muscle (LM), intramuscular fat (IMF), and subcutaneous fat (SF) in beef strip loin (Elliot, 2025) using shotgun lipidomics. The resulting mass spectra were analyzed to identify and provide absolute quantification for 882 distinct lipid species across the different tissue types. The study confirmed that each tissue contributes a unique lipidome. Fat depots (IMF and SF) were composed almost entirely of storage lipids (>96%), primarily triacylglycerols (TAGs), whereas lean muscle was markedly enriched in structural lipids - phospholipids and sphingolipids accounted for more than 30% of its total lipid content.

It is important to underline that the authors do not address sensory attributes such as taste, flavor, or palatability. Their objective was strictly biochemical: to generate a quantitative lipidomic characterization of lean muscle, intramuscular fat, and subcutaneous fat, and to clarify how each contributes to the broader ‘beef matrix’.

These compositional differences have methodological implications. If LM, IMF, and SF each carry distinct lipid classes and proportions, then ‘red meat’ is not a uniform type of food. The specific balance of lean and fat tissue becomes a critical variable that should be accounted for in nutritional epidemiology. Many existing studies on red meat consumption and health outcomes overlook this nuance and fail to specify the type of meat consumed or its degree of marbling.

Clinical studies further illustrate why this distinction matters. For example, lean red meat, when trimmed of visible fat and consumed within a diet low in saturated fatty acids, does not adversely affect plasma LDL cholesterol (Li, 2005). This clinical pattern is metabolically consistent with the observation that lean muscle is enriched in structural lipids rather than storage TAGs (Elliot, 2025).

Failing to differentiate lipid compositions in beef (and other red meat) introduces a substantial confounding variable that can negatively affect the analysis of the relationship between meat consumption and health outcomes. The conclusions from Elliot et al., therefore, argue that future research should stratify analyses by the type and composition of beef products to ensure greater accuracy and interpretability.

In summary, the health implications of red meat consumption are complex and depend on meat processing, the specific lipid composition of the cut, and the broader dietary matrix in which it is consumed.

Olya Vvedenskaya, MD, PhD

Lipotype

---

24 February 2026

A Lysolipid for Treating Obesity?

After the recent holidays, thoughts of overeating and obesity occupy an increased amount of space in our minds. Given this, and the interest of the readers of this blog, I thought it would be interesting to bring some attention to a recent article suggesting a mechanism by which obesity may be combated by using lysophospholipid, 1-linoleoylglycerophosphocholine (1-LGPC). This mechanism capitalizes on a new potential connection between 1-LGPC and the KEAP1-Nrfs (Kelch-like ECH-associated protein 1 - Nuclear Factor Erythroid 2-Related Factor 2) axis. This axis is a recognized cellular system that defend against oxidative and electrophilic stress. In this axis, KEAP1 binds NRF2 and tags it for degradation, and when stress signals are present (e.g. ROSs), KEAP1 releases NRF2 upon which it to enters the nucleus, bind to DNA, and activate protective genes such as antioxidant enzymes (e.g. HMOX1), detoxification enzymes (e.g. GSTs), as well as metabolic enzymes and enzymes involved in autophagy. In a recent article by Wang et al , the authors report a decline in 1-LGPC in the blood of obese patients. Interestingly, 1-LGPC reduced the high-fat diet-induced lipid accumulation in zebrafish larvae and in human adipocytes. Their data indicated that uncoupling protein 1-dependent thermogenesis and mitochondrial respiration were significantly boosted. Importantly, NRF2 expression and nuclear translocation were induced by 1-LGPC. Other data indicated the KEAP1-Nrf2 axis was involved in the 1-LGPC-induced energy expenditure. The authors suggest their results provide a new and interesting insight into a novel physiological role for 1-LGPC in obesity and points to a new target for treating obesity. I should note that there could approaches to confirm and strengthen their conclusions such as the use of another lysolipid, and an alternative to using brusatol such as an RNAi knockdown Nrf2. Nonetheless, their results are indeed intriguing.

Dan M. Raben

The John Hopkins University School of Medicine, Baltimore, MD, USA

---

3 February 2026

Pseudo-Leukotrienes: bioactive lipids generated through autoxidation during inflammation.

Lipid oxidation is catalyzed either by enzymes, or mediated by unregulated chemical processes involving redox active iron and/or highly reactive free radicals. For the latter, a complex back and forth of initiation, propagation and termination reactions results in a massive expansion of products formed. While tightly-regulated enzymatic oxidation generates bioactive lipids that play essential roles in physiology, non-enzymatic oxidation is generally considered toxic and a major contributor to tissue damage in both acute and chronic disease.

Despite their biosynthetic differences, there are major overlaps between these two processes driven by the structural similarities of the resulting products made. For example, it has been long known that non-enzymatically generated isoprostanes can act in similar ways to their cyclooxygenase-derived prostaglandin isomers, although generally this is with less potency and specificity.

Recently, extending our knowledge of the cross over between enzymatic and non-enzymatic oxidation, Robert Salomon’s group from Case Western University, Cleveland, identified a new family of radical-induced lipid oxidation products that they termed pseudo-leukotrienes (øLTs). These are proposed to be generated through AA oxidation (while AA is still in the phospholipid pool), followed by its truncation and PLA₂ cleavage to form HOOA (5-hydroxy-8-oxo-octanoic acid), which is followed by Michael addition of glutathione to form DHOA-GSH. Peptidase activity is then proposed to sequentially remove amino acids from the GSH to generate further metabolites, with the lipids given names reflecting their structural similarity to leukotrienes, øLTC, øLTD, øLTE and N-Ac-øLTE. Here, there are assumed to be 4 diastereomers due to the free radical processes involved. In a first paper, total synthesis approaches were used to generate internal and primary standards. These were then used to quantify the lipids in both this and a more recent paper , in biological samples that included retinal pigment epithelial cells, urine from asthma patients, and mouse lung following allergen exposure. Levels of the lipids were significantly higher in severe asthma (urine), and correlated with severity, and were also increased in BAL from mice with after allergen exposure. Last, it was shown that øLTs could induce signaling in cultured cells that was mediated via CysLTR, although with somewhat lower potency. Interestingly, the urine concentrations of these new molecules was far higher than those of CysLTs.

A major strength of the paper is the use of synthetic standards to confirm structure, and in the first paper, co-elution of øLTC in mouse lung homogenates with both the synthetic and labelled (³C₂¹⁵N) internal standards provided strong evidence, although a limitation is that only one MRM channel was followed and corresponding data for the other lipids weren’t shown. It can be challenging to obtain clean MS/MS spectra of (low abundance) endogenous lipids in complex tissues, so another approach, recently outlined in a community guideline for oxylipin analysis is to monitor secondary (or even tertiary) MRMs, which can then confirm that fragments of interest co-elute on LC with the lipid of interest and have the same ion ratios. It may also be interesting to run the biological extracts on a chiral column to determine the prevalence of the stereoisomers expected to also be present in these mixtures (to confirm their non-enzymatic origin in biological samples). For interested readers, all four of the lipids have now been added to LMSD (for øLTB, and replace the 2 with 3,4,5 to see the rest).

Relating to nomenclature, while the name pseudo-LTs is used here to denote GSH addition and its subsequent metabolism, as well as their ability to activate CysLTR, it’s noted that it this name formally refers to lipids with a triene structure, which isn’t present here. Perhaps a name that more accurately reflects the full structures of these molecules could be considered, so as to avoid potential confusion on this point.

Discovery of new lipids that signal in inflammation is a vibrant field and no doubt, there are many more lipids remaining to be uncovered that originate either from enzymatic or non-enzymatic oxidation of PUFA. Further studies will establish whether monitoring urinary levels of these new and unique lipids will be useful for monitoring asthma severity or guiding treatment choice, as outlined in the recent study.

Valerie O’Donnell,

Cardiff University

---

19 January 2026

Mechanistic snapshots of lipid-linked sugar transfer

I’m always drawn to articles that highlight the need for structural studies that AI approaches can’t resolve. That’s why I was drawn to a recent article in Nature Communications by Morgan et al titled “Mechanistic Snapshots of Lipid-linked Sugar Transfer". The authors used UV-photolysis of a chemically caged substrate with cryogenic time-resolved electron microscopy (cryo-TREM) to examine the catalytic mechanism of a membrane-bound glycosyltransferase, GtrB. They were able to visualize conformational changes during the catalytic cycle that moves each substrate, UDP-glucose and undecaprenyl phosphate, in proximity for catalysis. They were able to visualize the initial substrate-bound state, a catalytically poised intermediate, and the product-bound state involved in catalysis.They further supplemented their results with molecular dynamics simulations and biochemical analyses, to identify the conformations within the active site that drive catalysis. This in an intriguing studies that represents the power of structural biology approaches that provide an understanding of a catalytic that would be very difficult if not impossible to obtain with AI approaches alone. Structural biology is still alive and well.

Dan M. Raben

The John Hopkins University School of Medicine, Baltimore, MD, USA

---

6 January 2026

The elusive origin of brain DHA, and the importance of publishing replication studies.

Supplementation with omega3 fatty acids derived from fish oil has been promoted as a neutraceutical approach towards maintaining health for at least 50 years now, driven in the early days by epidemiological data on diverse inflammatory conditions including cardiovascular disease and latterly, by studies on dementia risk. Of course, epidemiology does not prove cause and effect and in more recent times, several randomized clinical trials have conclusively failed to evidence the attractive idea that these lipids might be a panacea for any chronic diseases of ageing. One major question in this field relates to the bioavailability of omega3 fatty acids when orally administered. Dogma has been that dietary forms should be absorbed then taken up into cell membranes, particularly in the brain, where they’ll magically (through largely unknown but oft debated mechanisms) prevent cognitive decline. But does this idea hold up?

At the recent Society of Chemistry in Industry meeting in London on Lipids in Diet and Health, there was lively discussion of this exact question, initiated by a presentation from Richard Bazinet on his recent study in J Lipid Res. This seminal paper discussed how the brain is unable to make its own DHA, so it relies on other sources to maintain the high levels required for normal brain function. Here, Klievik et al set out to re-evaluate a series of studies by Sugasini et al, where supplementation with either LPC-DHA or di-DHA-PC was claimed to increase brain DHA content by up to 2-3 fold in mice. This was prompted by a recent study showing in contrast, that LPC-DHA supplementation didn’t increase brain DHA levels in Apoe3 and Apoe4 knock-in mice, and because as the authors state, they “are not aware of any direct evidence supporting the intact absorption of sn-1 DHA into the plasma”. In summary, in the recent study from Bazinet and colleagues, while oral supplementation of DHA either as PC or LPC led to significant enrichment in plasma and heart lipid pools, brain DHA levels were completely unchanged. This agrees with more recent data on this question cited by Bazinet, supporting the notion that the brain self-regulates its DHA levels rather than being influenced solely by what happens in the diet.

The importance of this study is twofold. First, it’s essential to understand where the brain derives DHA from, and how this could be regulated therapeutically. This study shows that in mice this is not from diet, leaving endogenous synthesis as the source. Indeed, in his seminal lecture at the SCI meeting, Richard presented new data beyond the published study, using natural abundance carbon isotope ratio analysis to demonstrate that DHA in the brain originates from endogenous synthesis. An earlier JLR paper describes this method.

The second reason that this paper is important is that it’s a replication study, performed in response to conflicting literature on the topic. Science depends on careful replication of key findings and all too often this doesn’t happen at all, or if it does, it occurs many years later having followed a long period of wasted time, funding and lost careers. Publication of negative data is difficult and hard work for all involved but it’s an essential part of science if we are to ensure the record is accurate. The field of omega3 fatty acids isn’t unique in facing this issue, nor are the issues addressed in this study by any means the only question marks hanging over fish oil neutraceutical claims. The editors of JLR should also be commended for supporting publication of replication studies, upholding standards in research through providing opportunities to correct and debate research respectfully through the process of peer review.

Valerie O'Donnell

Cardiff University

---

30 December 2025

Structural Insights into TMEM164-mediated Phospholipid Remodeling Involved in Ferroptosis

Ferroptosis is gaining increasing attention. This process is an iron-dependent cell death that involves the accumulation of lipid peroxides and the oxidation of polyunsaturated fatty acids (PUFAs) with a particular role for ether-linked PUFAs. TMEM164 is a transmembrane acyltransferase involved in ferroptosis catalyzing the formation of the ferroptotic C20:4 ether-linked phosphospholipids (ePLs). Consistent with this, cells lacking TMEM164 showed a selective reduction in ePLs, and genetic ablation of TMEM164 protects cells from ferroptosis. Recently, Ke et. al presented a cryo-EM study revealing a structural understanding of the role of TMEM164 in the lipid remodeling involved ferroptosis. The authors show that TMEM164 overall architecture is a dimer of two 7 transmembrane domain monomers with a metal ion bound catalytic center. Further, the authors identified a phospholipid substrate in a PUFA-bound in an intermediate state to cysteine 123 in the catalytic center. Interestingly, both loss and gain of function leads to a decline of PUFA-ePE and elevation of C16/18:1-ePE which confers resistance to the glutathione peroxidase 4 inhibitor RSL3-induced ferroptosis. Mutagenesis studies further validate critical residues for the catalytic center (C123) and the chelates center (E106, Y177 and H181). This work demonstrates structural feathers of TMEM164 as a membrane lipid remodeler which modulates ferroptosis.

Dan M. Raben

The John Hopkins University School of Medicine, Baltimore, MD, USA

---

23 December 2025

A Lysolipid for Treating Obesity?

Holidays are upon us and thoughts of overeating and obesity occupy an increased amount of space in our minds.Given this, and the interest of the readers of this blog, I thought it would be interesting to bring some attention to a recent article suggesting a mechanism by which obesity may be combated by using lysophospholipid, 1-linoleoylglycerophosphocholine (1-LGPC). This mechanism capitalizes on a new potential connection between 1-LGPC and the KEAP1-Nrfs (Kelch-like ECH-associated protein 1 - Nuclear Factor Erythroid 2-Related Factor 2) axis. This axis is a recognized cellular system that defend against oxidative and electrophilic stress. In this axis, KEAP1 binds NRF2 and tags it for degradation, and when stress signals are present (e.g. ROSs), KEAP1 releases NRF2 upon which it to enters the nucleus, bind to DNA, and activate protective genes such as antioxidant enzymes (e.g. HMOX1), detoxification enzymes (e.g. GSTs), as well as metabolic enzymes and enzymes involved in autophagy. In a recent article by Wang et al (J Lipid Res. 2025 Nov;66(11):100914), the authors report a decline in 1-LGPC in the blood of obese patients. Interestingly, 1-LGPC reduced the high-fat diet-induced lipid accumulation in zebrafish larvae and in human adipocytes. Their data indicated that uncoupling protein 1-dependent thermogenesis and mitochondrial respiration were significantly boosted. Importantly, NRF2 expression and nuclear translocation were induced by 1-LGPC. Other data indicated the KEAP1-Nrf2 axis was involved in the 1-LGPC-induced energy expenditure. The authors suggest their results provide a new and interesting insight into a novel physiological role for 1-LGPC in obesity and points to a new target for treating obesity. I should note that there could approaches to confirm and strengthen their conclusions such as the use of another lysolipid, and an alternative to using brusatol such as an RNAi knockdown Nrf2. Nonetheless, their results are indeed intriguing.

Dan M. Raben

The John Hopkins University School of Medicine, Baltimore, MD, USA

---

25 November 2025

Potential Treatment Avenue on the Horizon for Neimann-Pick Disease Type A?

We have known for some time that Niemann-Pick Disease (NPD) is a genetic disorder that leads to fat accumulation is various tissues such as liver, spleen, and brain. When I asked folks about NPD, it is common for me to hear that lysosomal cholesterol transporters are defective in this disease. Actually, there are three major types of NPD designated as Types A, B, and C, with Type C involving the defective lysosomal cholesterol transporters designated NPC1 and NPC2. The genetic defect in Types A and B, however, appears to involve dysfunctional acid sphingomyelinases (aSMases), encoded by SMPD1 gene, which hydrolyze ceramide as well as phosphatidylcholine. The difference between NPD-A and NPD-B is that the mutation leading to NPD-A leads to a near-complete loss of SMase activity, while enzyme mutations leading to NPD-B retains some modest activity. These mutations are significant to patient outcomes as those with NPD-A rarely live more than 3 years of age, while those with NPD-B may live to adolescence or early adulthood without serious neurological difficulties. In a recent paper by Beard et al. generated a mouse model in which mice harbored a S505A mutation (aSMase^S505A), which corresponds to the S507A mutation in humans retained L-SMase activity and tissue sphingomyelin levels in the brain. Interestingly however, these mice lacked S-SMase activity in serum. ASMase^S505A mice also also protected from NPD physiology and pathophysiology responses. Importantly, aSMase^−/− mice that showed significant decreased locomotor control, was prevented in aSMase^S505A mice. The authors suggest that their results suggest that expression of L-SMase may serve to pave the way for enzyme replacement therapy in humans with in NPD.

Dan M. Raben

The John Hopkins University School of Medicine, Baltimore, MD, USA

---

10 November 2025

Neurolipid Atlas, a lipidomics resource for neurodegenerative diseases.

Our brains represent complex biochemical landscapes, with a lipidome that’s long been known to be different to that of other organs, for example being highly enriched in long chain PUFA such as DHA and EPA. While lipid changes in the brain are increasingly implicated in neurodegenerative disease, many gaps in our knowledge about how they respond specifically and precisely during health and disease remain. Aiming to facilitate research in this area, Feringa et al recently published a resource that uses lipidomics to describe which lipid species are present in specific cell types, also including several derived from iPSCs, which are increasingly used as a tool for mechanistic neurological and neuropsychiatric research.Importantly, the project provided an opportunity to screen for lipidomic differences across multiple cell types and also whole brain tissue from humans and mouse models of disease, resulting in several interesting discoveries. One notable finding relates to the Alzheimers disease (AD) risk allele, APOE4, which the study showed was associated with cholesterol ester accumulation in astrocytes and in brains of patients with AD. Altered cholesterol metabolism was also demonstrated during astrocyte immune regulation, potentially linking this process with AD pathology. The full dataset has been made available in an online repository which allows users to both browse, and importantly, to add further data from their own research.

Making available comparative data on lipid composition (at an organ, tissue, cellular or even sub-cellular level) is a topic that often comes up when we talk to users of LIPID MAPS. A data repository that describes what constitutes a brain or a liver lipidome is an attractive concept for the field, however, this is an area that’s difficult to support at scale for both methodological as well as theoretical reasons. First, lipidomes are not generally unique across tissues/organs/cells. More often than not (if we consider mammals) specific lipids will show relative differences in amounts, not an absolute presence or absence. This means that defining a lipid composition that’s characteristic of brain versus liver or kidney is extremely challenging and the best we could say is that one tissue is enriched or relatively-deficient in particular species. Focusing on one type of organ, and comparing different cells within that organ, or different diseases is one way around this, with the caveat being that a valid comparison requires either the same assay to be performed on the same instrument to generate all the data, or highly validated quantitative values need to be generated using the same assay (if the analysis is performed by more than one lab). In the case of Feringa et al, to overcome these issues, all the measurements were made using a single pipeline on one machine (Lipidyzer, on a Sciex QTrap) allowing all samples to be directly compared within this study. The repository provides a very useful model for focused questions to be posed while comparing large numbers of lipids at scale in a single organ or tissue type. It will be interesting to see how/if data deposited by other researchers in the future, but generated using different platforms, can be integrated with currently deposited data in a meaningful way. Wider than this study, this is a major challenge for the field of systems lipidomics in general, where data reuse is becoming a significant research endeavour in its own right.

Valerie O’Donnell, Cardiff University.

---

28 October 2025

Mitochondrial NADPH fuels mitochondrial fatty acid synthesis and lipoylation to power oxidative metabolism

Nicotinamide adenine dinucleotide phosphate (NADPH) is a well-known cofactor involved in a variety of biosynthetic pathways as well as participating in the prevention of oxidative stress. This cofactor is confined to the cytosol and mitochondria.It is known that the principal enzyme involved in the production of mitochondrial NADPH is NAD+ kinase 2 (NADK2) which catalyzes the phosphorylation of NAD+ and ATP or polyphosphates. A report by Kim et al. has shown that in addition to this role, NADK2 is essential for maintaining the level of protein lipoylation, the posttranslational modification of specific lysine residues with lipoic acid. This modification has been found on some of the TCA cycle enzymes such as pyruvate dehydrogenase and assembly of the electron transport chain. In addition to the role of NADPH as a cofactor in mitochondrial fatty acid synthesis (mtFAS), NADK2 is also involved in the translation of genes involved in this pathway. Overall, their data show that NADK2 plays a critical role in mtFAS activity, cellular respiration, and mitochondrial translation.

Dan M. Raben

The John Hopkins University School of Medicine, Baltimore, MD, USA

---

30 September 2025

ABDH18: A Newly Identified Cardiolipin Deacylase

Cardiolipin (CL) is a unique phospholipid composed of two phospholipids, four fatty acids, linked together by a glycerol group resulting in a central hydroxyl group. This phospholipid is essential for a number of mitochondrial functions. Interest in this CL results largely from its clinical impact in that defects in the synthesis of this lipid leads to a rare but devasting syndrome referred to as Barth syndrome. CL is synthesized on the inner mitochondrial membrane. An important step in the synthesis of mature CL involves remodeling of the de novo CL species involving the exchange of nascent acyl chains with longer, unsaturated chains. The gene involved in Barth syndrome has been identified as a mutated TAFAZZIN (TAZ) transacylase which is the final enzyme involved in CL-remodeling. This mutation leads to an accumulation of monolysocardiolipin (MLCL). Interestingly, the enzyme responsible for the generation of MLCL has been known in yeast (Cld1), the homologue in plants, animals, and humans remained a mystery until the publication of two recent papers. Both of these reports identified ADH18, a deacylase which converts CL into MLCL Masud et al, and Ren et al . These studies used human HAP1 cells (Masud et al.) as well as mouse myocytes and Drosophilia (Ren et al.) model systems. In both studies, inhibition or suppression of ADH18 resulted in a suppression of the accumulation of MLCL and appears to rescue TAZ mutant phenotypes. Interestingly, suppression of ABHD18 led to more saturated acyl chains typical of CL in both studies. The Ren et al paper suggested that, in cells, ABHD18 did not deacylated CL species with more than five double bonds. This is interesting as it suggests potential regulatory mechanisms such as substrate specificity, or a modulation by membrane architecture or interaction with other membrane proteins. Both studies, however, support a critical role for ABHD18 in CL biosynthesis and offer an exciting and much needed potential therapeutic target for Barth syndrome. Both papers are interesting to read.

Dan M. Raben

The John Hopkins University School of Medicine, Baltimore, MD, USA

---

2 September 2025

Quantitative imaging of lipid transport in mammalian cells

How Lipids Get to Where they Need to Be

We all have all been taught that intracellular membranes contain specific lipid species with specific headgroups and constituent fatty acids in specific proportions. How this distribution is established has long been a mystery for most lipids. Using a combination of pulse-chase fluorescent lipid probe imaging coupled with ultra-high-resolution Fourier-transform (FT) mass spectrometry (MS) and mathematical modelling the authors have quantitatively mapped the kinetics of -specific lipid transport and metabolism. Interestingly they propose they have identified the primary mechanism involved in lipid sorting to specific organelle (Iglesias-Artola et al. Nature 2025 Aug 20.- Online ahead of print). The authors investigated the movement of modified, phosphatidycholines, phosphatdic acids, and phosphatidylethanolamines. As endocytic trafficking of sphingomyelins has been well characterized, the authors included modified sphingomyelin in this study. Their studies suggest that fast, species-specific lipid sorting occurs via directional, non-vesicular lipid transport and non-vesicular lipid transport also dominates the organelle distribution of lipids. Interestingly, the authors provide data implicating flippases engaged in species-selective flipping in establishing in establishing and maintaining organelle membrane lipid composition. The authors further suggest that the species-specific metabolism of phospholipids controls neutral lipid metabolism. Refreshingly, the authors also point out important that their study can falls short of being able to mimic the behavior of fully saturated lipids and they are not able to lipid exchange between organelles far from the plasma membrane. Overall, their approach, however, is an interesting approach to study how lipid distribute within cells and their potential impact on cell biology.

Dan M. Raben

The John Hopkins University School of Medicine, Baltimore, MD, USA

---

18 August 2025

Every 5-10 years or so, new innovations in mass spectrometry come along that drive a step-change in how we see lipids in biology. For example, benchtop instruments which were developed around 2005 kick-started the lipidomics revolution, while untargeted screening methods initially applied to metabolomics around 2012 led to a huge interest in surveying not only what we knew, but what we didn’t know. Along with each new MS approach, software has come along that allowed us to make sense of what we found, enabling us to mine and uncover new lipids through analysing the huge amounts of information contained in these massive experiments.

Despite the advantages of switching from GC/MS to LC/MS that took place around 2005 when benchtop instruments arrived, one clear disadvantage was the loss of structural information generated using this method. This is because ionisation and fragmentation methods used with LC/MS/MS are considered “softer” and don’t achieve the same level of fragmentation as electron impact or chemical ionisation used with GC/MS. While this is fine for simple quantification of well-characterized molecules it means there a significant loss of information and makes the working out of novel lipid structures far more challenging, as well as making it impossible to discriminate what could be many different molecules from each other in a single biological sample.

Addressing this issue, recent innovations over the last 5 years focused on “enhanced fragmentation modes”, of which there are several including UV photodissociation (UVPD), ozone-induced dissociation (OzID), electron activated dissociation (EAD), Paternò–Büchi (PB) and oxygen activated dissociation (OAD). Combined with today’s powerful high resolution MS instruments, these fragment either at C-C bonds, or selectively at C=C double bonds, providing richer information on structure that enables the diversity of FA containing molecules to be more comprehensively profiled in large scale cataloguing experiments in a way that GC/MS instruments could never have done.

Along with this, interest in using retention time to discriminate structures has emerged. The first papers on this appeared around 2014, when Choi et al developed a phosphatidylcholine retention time index to support identification, followed in 2016 by a study from the Holčapek group showing how relative carbon and double bond numbers could predict retention time behaviour for over 400 lipids in 14 classes (5 categories of lipids). Adding to this, a new paper in Nature Comms last week, from Lamp et al shows how retention time can be used to assign chain-specific C=C positions for lipids, in particular determining the ω-positions. To develop the database of verified identifications, the authors used a stable isotope labelling approach supplementing RAW cells with FA of varying w-composition to alter the endogenous lipid pool, enabling identification of specific lipids enriched with labelled FA, as well as their metabolites. A machine learning-based retention time mapping approach was then developed to extend the identification of lipids to over 2.4K. A tool was developed which allows other researchers to apply this method to their own data moving forward.

A central question with this approach is how well a predictive machine learning method maps to real life data, which can only be generated experimentally. In response to a reviewer request, the authors conducted EAD and benchmarked their method against published papers using PB or OzID showing close alignment, and supporting the validity of the approach. The full validation data for the EAD comparison is deposited online.

Applying the approach to a real-world biochemical question, it was then asked (using existing published data) whether C=C positional specificity at either Sn1 or Sn2 dictated cPLA₂’s substrate preference. Several new findings were revealed including that the enzyme has a similar specificity for mead acid (MA, 20:3(n−9)) as it does for AA, however that wasn’t the case for 20:3(n−7) and 20:3(n−6), which turned out to be poor substrates. Overall, the study demonstrates elegantly how this approach can be applied to existing studies, where full chromatographic data is available, to extend our knowledge of the biochemistry of complex lipid metabolism, without the need for new experiments. As we move forward the mining of rich data housed in publicly accessible databases using methods like this will undoubtedly lead to many further insights into lipid metabolism.

Valerie O’Donnell, Cardiff University.

---

5 August 2025

Boswellic Acid Anyone?

Boswellia carterii is probably most popular for its oil referred to as Frankincense. This oil has been used in soaps, skin care products, and aroma therapy. Therapeutically, it has also been suggested to be cytotoxic for some tumors. It now appears that another product from this tree may be effective for treating non-alcoholic fatty liver disease (NAFLD) and its associated complications. NAFLD affects approximately 30% of the world’s population and while it occurs in diverse populations, there is an unfortunate rising incidence of obesity and NAFLD in pediatric populations. Such an increase represents an alarming potential for further increases in pediatric insulin resistance. This recognition has led to increased attention on identifying effective pharmaceutical approaches for treating NAFLD and its related metabolic disorders. In a recent study by Luan et al in the Journal of Lipid Research it appears that another product from Boswellia carterii, 3-acetyl-11-keto-beta-boswellic acid (AKBA) may be an effect agent for the treatment of NAFLD including the associated weight gain and insulin resistance.Using a mouse model and cultured hepatocytes, the authors showed that the mechanism of boswellic acid effects involved a direct interaction with monoacylglycerol lipase (MGLL) in hepatocytes and their studies highlighted an important role for MGLL in NAFLD.

Dan M. Raben

The John Hopkins University School of Medicine, Baltimore, MD, USA

---

21 July 2025

Schools out for summer

While many of the schools in the northern hemisphere are on ‘Summer break’, have you ever given thought to the link between lipids and the holidays?

A 2024 paper, by Eglitis. et al. demonstrates that summer holidays can put children at risk for weight gain and less healthy habits—but structured summer programs can help reverse that trend.

Without structured routines, children tend to: Have less active time, Spend more time on screens, Skip physical activities, & Possibly eat more junk food

The systematic review and meta-analysis looked at 10 controlled studies including 1,446 children aged 5–18. This data showed that those who attended summer camps, and thus were more active had a healthier weight (a small reduction in adiposity) at the end of the summer compared to those who hadn’t attended any camps.

This study did not measure lipid profiles (e.g., cholesterol or triglycerides), however other studies have established that increasing activity and reducing adiposity typically improve lipid profiles, especially in children who are overweight.

In a similar paper from 5years previous, a similar conclusion was also reached: Larose et al.,2019 mapped interventions in summer camps across North America and Europe targeting physical activity, sedentary behaviour, and diet in children aged 6–16. Their findings highlighted modest but meaningful improvements: increased activity, healthier eating, and reduced screen time.

While Larose et al.'s review focused on movement and diet, its positive outcomes form a strong bridge to lipid health. Increased activity and better nutrition in childhood are proven to improve cholesterol and triglycerides, setting the stage for lifelong cardiovascular wellness.

Summer programs act as a public health buffer, offering scaffolded days that replicate school-like structure with adult supervision, planned activities, healthy meals, and peer interaction—promoting healthier movement habits and body composition.

Lauren Cockayne

Cardiff University - LIPID MAPS

---

24 June 2025

Lipid peroxidation induces formation of aldehydes that are well known to react with primary amines to form novel structures. One class of these molecules is represented by covalent adducts of aldehydes with phosphatidylethanolamine (PE) headgroups, called N-aldehyde-modified PEs, NALPEs).Large numbers of these lipids are already known, including forms modified by malondialdehyde (MDA), 4-hydroxynonenal (HNE) and Isolevuglandins (isoLG), and some of these have been shown to have biological effects that are generally considered proinflammatory.

A recent study from the Davies lab at Vanderbilt (Fadaei et al) has expanded our knowledge of how these interesting lipids could be metabolized if/when they are formed in vivo.Specifically, they focused on N-acyl PE-hydrolyzing phospholipase D (NAPE-PLD), an enzyme already known to metabolize PEs that have been modified enzymatically by addition of acyl chains greater than 4 carbons in length, termed NAPEs. In this study, the authors first identify many previously undiscovered NALPEs that are formed in complex lipid oxidation mixtures. They then go on to show that NAPE-PLD can indeed hydrolyse these diverse NALPEs generating the corresponding phosphatidic acids (PA).

NAPE-PEs are formed endogenously by enzymatic acylation reactions and have been demonstrated to form in vivo in mammalian tissues for many years already, for example, as part of the biosynthetic pathway leading to formation of N-acylethanolamines (NAE). On the other hand, there seems to be only few reports of NALPE-PEs being formed in vivo, for example, a paper from 2009 from the Salomon group, that used LC/MS/MS to show the presence of LG and isoLG adducts that form with PE, then ultimately further oxidize to form stable lactams and hydroxylactams. Interestingly, in that paper they did not find the intact PE, with both acyl chains attached, and instead, their detection required prior treatment with PLA_2. This released the Sn2 FA, with the result being that all species with the same Sn1 FA when totalled together, rose above the instrument limit of detection and could be identified. Levels of these lipids were increased in livers from ethanol fed mice and human plasma from patients with age related macular degeneration. Considering the work was done several years ago, and MS instrument sensitivity for quantitation is probably around 100+ fold higher than it was back then, it would be interesting to revisit this work without PLA₂ hydrolysis and try to map the specific lipids as intact species. Also, additional structures now identified by Fadaei et al might also be identifiable using the newer generation instruments.

Valerie O'Donnell

Cardiff University

---

6 June 2025

Implication of CDP-DAG synthases in plant growth and disease resistance

While many of us focus on mammalian lipids and lipid metabolism, there are often reports that remind us of the interesting aspects of plant lipid metabolism. Such is the case with a recent report by Tan et al. In addition to phosphatidic acid (PtdOH) playing important signaling roles in mammals and plants it is subject to multiple routes of metabolism. One of its metabolic routes is its conversion into cytidine diphosphate diacylglycerol (CDP-DAG) by CDP-DAG synthases (CDSs). In the report by Tan et al, while the knock-down of the CDS genes, cds1 and cds2, suppressed the growth of Arabidopsis thaliana, it also provided resistance to multiple pathogens.

The level of reactive oxygen species (ROS) production induced was significantly higher cds mutants than that in wild-type (WT) leaves. Additionally, phosphorylation of mitogen-activated protein kinases (MAPKs) in the cds mutant was increased compared to the WT. The authors then employed a lipidomic, transcriptomic, and metabolomic approach, the authors provide evidence that an accumulation of PtdOH in the cds mutant, led to the activation of the jasmonic acid (JA) and salicylic acid (SA) signaling pathway, and increased transcript levels of known plant defense-related genes. Interestingly, downstream metabolites involved in in plant immunity also increased.

It is not surprising that levels of the non-amine phospholipids, such as phosphoatidylinositol, was decreased as CDP-DAG is involved in the synthesis of this lipid. It is curious, however, that the levels of amine phospholipids, such as phosphatidylethanolamine and phosphatidylcholilne, as well as their lysolipid counterparts were elevated perhaps as a compensatory mechanism. Nonetheless, the authors suggestion that their data provides evidence that CDSs may play role(s) in metabolic regulation and disease resistance in Arabidopsis is intriguing. Indeed, their data may suggest there are some unappreciated roles for CDS genes in mammalian cells as well.

Dan M. Raben

The John Hopkins University School of Medicine, Baltimore, MD, USA

---

27 May 2025

This week, I’m blogging about a recent article published in Science Signaling, which represents the culmination of around a year and a half’s work by the International Lipidomics Society Oxylipin Interest Group, on community-agreed recommendations for oxylipin analysis. A preprint link is also here.

A relatively short focus article introduces the main supplement which then provides more in-depth information on how the project came about, as well as a wealth of information for researchers, on the analytical factors that need to be accounted for when measuring and reporting on these lipids.

Of course, most of the recommendations are not specific to oxylipins, and are more broadly relevant, for example describing how to make a reasonably educated judgement about whether a molecule is or is not actually present in a sample is not just specific to one category of lipids but applies more broadly to analysis of all molecules using chromatographic methods.

The story behind this article is familiar to many of us working in the field; there was an acknowledged need for consistent approaches to ensure data quality when measuring and reporting these lipids. Where levels of oxylipins are low or below limit of detection of a method, over-interpretation of poor data could lead to errors, and since much of our research into oxylipins could either indirectly or directly impact patients at some point down the line, then we have a duty to ensure we’re working in line with best practice.

One consideration we had when approaching this project is that most of us are not working with clinical grade assays in our labs, and the sort of validation required for a precise estimation of actual amounts in human samples for diagnostic purposes wasn’t going to be feasible for the majority of our studies, or necessary. So, we needed to take a pragmatic approach. Taking into account the approaches being used in the clinical domain was essential, and to that end, we had expert advice from colleagues working at the Centre for Disease Control and the Clinical and Laboratory Standards Institute, in the USA, who described in detail how they apply formal guidelines, e.g. from CLSI, FDA, EMA and others, to their routine quantitative pipelines. This was enormously helpful, and it also revealed how easy it can be to make mistakes by adopting selected aspects of clinical recommendations into research grade workflows, mis-using them and drastically overestimating the level of confidence in detecting a molecule.

The process for developing this recommendation is worth a mention as it serves as an excellent model for this type of work. ILS have an Interest Group format where the community are all invited to take part and input, through open forums. This was a perfect way to bring the community together and invite open discussion.Following a series of initial webinars, led by a small core group (chaired by myself), a draft was written (by Nils Schebb) and eventually almost 100 researchers became co-authors of the final article. To complement this, LIPID MAPS have just released an oxylipin standard spectral library, already with contributions from 3 laboratories already, and a 4^th shortly to be added. The aim here is to have a curated set of spectra generated using several different platforms for most or all of the available standards of oxylipins, that is searchable and downloadable and can be used to aid in identification of lipids in biological samples (https://lipidmaps.org/databases/oxylipin/browse).

Valerie O’Donnell, Cardiff University

---

5 May 2025

The Antidepressive Drug Sertraline Inhibits Phosphatidic Acid Phosphatases

Sertraline, commercially known as Zoloft, is a well-recognized selective serotonin reuptake inhibitor (SSRI) widely used in the treatment of depression. SSRIs are also known to be useful anti-fungal agents although the mechanism of this activity remains unclear. While this mystery still prevails, new evidence from the Carman lab suggests an intriguing player may be a phosphatidic acid (PA) phosphatase (PAP). This enzyme catalyzes the Mg⁺² -dependent dephosphorylation of PA leading to the generation of diacylglycerol. Stukey et al, recently reported the ability of sertraline to noncompetitively inhibit the Saccharomyces cerevisiae PAP enzyme termed Pah1 which led to a decrease in triacylglycerol synthesis. The noncompetitive inhibition mechanism was substantiated by molecular docking of sertraline, as well as the well-established PAP inhibitor propranolol, to non-catalytic sites in the haloacid dehalogenase-like domain of Pah1. Consistent with the potential importance of this drug in humans, the authors showed the ability of sertraline to inhibit the human PA phosphatases α, β, and γ which are lipin 1 orthologs of Pah1. These studies should inspire future studies to examine the role of lipin-mediated lipid metabolism in modulating depressive symptoms in humans.

Dan M. Raben

The John Hopkins University School of Medicine, Baltimore, MD, USA

---

15 April 2025

Today’s blog comes from the end of the Keystone Symposia Lipids in Cellular Function and disease, which took place over the last week in Breckenridge, Colorado.

I’ve been honoured to act as co-chair with Junken Aoki and Vytas Bankaitis at this wonderful meeting which hosted research from across the globe into the roles of our favourite molecules, lipids, in driving underpinning mechanisms of health as well as how they contribute to causing human illness. A major strength of this meeting has always been the focus on basic biochemical processes, discovering new lipids and metabolic pathways and then mapping these onto the wider context of whole-body regulation and this meeting was no exception. Indeed, among the many highlights were new metabolic pathways and therapeutic applications for oxylipins (glucuronidation, clinical trials, clinical assays), discovery of new enzymes involved in phospholipid metabolism (Lands cycle, BMP synthesis), a huge focus on sphingolipids which included new molecules discovered, and their roles in metabolic disease, and novel insights into ferroptosis, a cell death process now reaching maturity with emerging clinical applications. There were so many great discussions, with robust and open Q&A sessions, and engaging and enthusiastic poster conversations, all signs of people having fun discussing science, learning and exploring as it should be. Working with Keystone also deserves a mention, they are truly a great organisation, supporting science and scientists with passion, professionalism and a sense of fun, exemplified by the new entertainment programme of music bingo on the last night hosted by Debbie and David.

On the other hand, it’s impossible not to mention the wider context in which this meeting took place. Many heartbreaking stories of the damage the current administration is doing to science abounded. From the loss of federal teams and committees charged with maintaining and improving provision of healthcare to the US population, to the wholesale cancelling of training grants because they used terminology the administration don’t approve of, to the many investigators waiting day by day to find out if they even have funding to pay their staff it was as bad as we have been hearing, and worse. Decisions aren’t made logically but arbitrarily which means they are unpredictable and impossible to fight. Damage limitation one day doesn’t work the next as the goalposts shift unexpectedly making the horizon move away. Not only researchers but associated industries that support research are all badly affected with all this compounded by the impact of tariffs. The carnage being inflicted on the epicentre of the world’s global science base is truly shocking. We can only hope that there’s a seismic shift soon before it’s too late, to return some sense of sanity and prevent this jewel in the crown from being irreversibly lost. We wonder how we can help, but it’s not obvious other than to support our US colleagues with a shoulder to cry on and practical help if that’s at all possible.It’s not much but having come here (at least, without any problems crossing the border) I can see how important it is to my colleagues to continue to maintain some semblance of control, a view of normality and a sense that despite all this, there will be a way out the other side.

We in Europe have looked to US science to provide a marker in the sand for global innovation, cutting edge progress, major discovery, collaboration and passion for research for almost a century. Seeing the erosion of this is profoundly depressing. These shifting sands don’t make for stability, they sow division and lead to conflict. Although this may seem obvious, it’s not something that the powers that be over here seem to have any care about as they go thrashing through the infrastructure with no thought for what’s being lost. As someone who grew up in the era before MMR, but never having had measles, I had my first dose of this lifesaving vaccine two weeks ago, just before coming to Keystone. NHS eligibility includes lack of being vaccinated and travel to an area with active outbreaks of disease. This is the first time I have been vaccinated for any communicable disease before travelling to the US and serves as a sign of where we’re headed if things don’t start to improve soon. Yesterday, in some sort of turn around, RFJ said “The federal government’s position, my position, is that people should get the measles vaccine,….”. Let’s hope we see a reversal of other ill-informed health related decisions soon, before more people die unnecessarily. If you want to learn how universities are dealing with these issues, listen to the President of Princeton University talk with bravery and passion about the impact of the cuts on his university, as published in the New York Times and available here.

Valerie O'Donnell, Cardiff University

---

19 March 2025

A Positive Feedback Loop of PIP5K-mediated production of PI(4,5)P₂

The role of phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P₂) in signaling cascades is now recognized as a paradigm of lipid signaling. Indeed, it’s difficult to read any review of lipid signaling pathways and not see a reference to the “PI Cycle” in which PtdIns(4,5)P₂ plays a central role. As a result, my posts often try to focus on other lipids to highlight the important role of other members in this family of biological molecules. Recently, however, a paper by Duewell et al. caught my attention given its focus on increasing our understanding of the structural elements of an important interfacial lipid metabolizing enzyme, phosphatidylinositol-4-phosphate 5-kinase (PIP5K). This enzyme is a major enzyme involved in the generation of PtdIns(4,5)P₂ by catalyzing the phosphorylation of PtdIns(4)P at the plasma membrane. In a previous publication, the authors showed that PIP5K displays a positive feedback loop which involves membrane-mediated dimerization and cooperative binding to its PtdIns(4,5)P₂ product. The recent report by Duewell et al. identified structural motifs involved in PIP5K recognition of PtdIns(4,5)P₂ and dimerization. Using TIRF microscopy and kinetic analyses, they provide a model whereby PIP5K cooperatively engages with PtdIns(4,5)P₂ mediated by an N-terminal region termed the specificity loop. Further, after orienting the enzyme on the membrane, the enzyme binds PI(4,5)P₂ near the active site through a motif previously referred to as the substrate or PIP-binding motif (PIPBM). Their data supports an intriguing model in which the specificity loop and PIPBM act in concert to orient PIP5K on the membrane and modulate its catalytic activity resulting in a positive feedback loop during PI(4,5)P₂ production.

Dan M. Raben

The John Hopkins University School of Medicine, Baltimore, MD, USA

---

5 March 2025

New phospholipid remodelling enzymes that generate fatty acyl thiamine esters

Cells dynamically remodel their phospholipid membranes to ensure that their molecular species compositions are in line with the requirements of their specific tissues. For example, immune cells contain many plasmalogens, while brain has a high proportion of longer chain n3 PUFA. Membranes are also remodelled in response to acute challenge, e.g. following agonist activation of platelets or white cells. The classic pathway for this is the Lands cycle, described by Bill Lands in the 1950s, which utilises families of enzymes from the ACSL and LPLAT/MBOAT families. These show strong cell and tissue specific expression patterns.  Over the last several decades, many of these enzymes with differing PL and FA specificities have been discovered and characterised and as they increased in number and complexity, a new nomenclature was proposed in 2022 by Shindou et al.

Recently, a new study in Science Advances from the Petkevicius lab at the MRC Mitochondrial Biology Unit in Cambridge has identified that a family of poorly understood TRAM-LAG-CLN8 domain (TLCD) containing proteins also can act as phospholipid remodelling enzymes, regulating cellular lipid composition and generating novel esters as biproducts. 

What’s also very interesting about this study is that it’s the first identification of new lipids comprised of fatty acyls attached to thiamine, which the authors proved using labelling studies, revealing palmitic, stearic and oleic-thiamine esters. These were identified in Hela cells and were dependent on expression of TLCD1 (and this was conserved in both yeast and worm).It will be interesting to see how this develops, in particular whether these novel products display unexpected biological roles.

Importantly, Sheokand et al also show that one of these proteins is a lysoPG acyltransferase, participating in lysosome function. Specifically, CLN8 is involved in generation of bis(monoacylglycero)phosphate (BMP), identifying a new way to form this family of lipids, of direct relevance to Battens disease where mutations in the protein are directly implicated.

Valerie O’Donnell, Cardiff University

---

19 February 2025

Lro1 Regulates Endoplasmic Reticulum Biogenesis.

One of the ever present and interesting biological mysteries is how cellular organelles regulate their size.  In a recent study by Lysyganicz et al, the authors present some intriguing evidence regarding the role of a phospholipid diacylglycerol acyltransferases (PDAT) termed Lro1 plays a key role modulating endoplasmic reticulum biogenesis in yeast. This is interesting as we all learned that triglycerides are classically generated via the hydrolysis of phosphatic acid to diacylglycerol which is then acylated using a fatty-acyl-Coa catalyzed by diacylglycerol O-acyltransferases (DGATs). Using a catalytically depressed Lro1 variant, however, the authors provide evidence that Lro1 modulates ER membrane expansion driven by phospholipid synthesis.  Interestingly, the authors show that the subcellular distribution, and subsequent membrane turnover, of Lro1 are controlled by production of diacylglycerol via the phosphatidic acid phosphatase Pah1. The authors suggest that their data implicates a lipid-metabolic network involved in regulating endoplasmic reticulum biogenesis that involves converting phospholipids into storage lipids.

Dan M. Raben

The John Hopkins University School of Medicine, Baltimore, MD, USA

---

23 January 2025

De novo lipid synthesis and polarized prenylation are involved in cell invasion

As has been known, during development, immune surveillance, and in cancer metastasis, cells must breach and clear basement membrane barriers.  It appears that large, transient, specialized lipid-rich membrane protrusions are used in this process.  One popular model system used to examine this process is the anchor cell invasion of Caenorhabditis elegans. In a study published in July, Park et al. used live imaging, endogenous protein tagging, and cell-specific RNAi show that lipogenesis and a polarized lipid prenylation drives for formation of the invasive protrusion of the anchor cells.  The SREBP-dependent expression of fatty acid synthesis enzymes POD-2 (acetyl-CoA carboxylase, ACC), FASN-1 (a fatty acid synthase), the ZMP-1 matrix metalloproteinase and the endoplasmic reticulum localized HMG-CoA reductase HMGR-1, which generates isoprenoids for polarized prenylation, are all involved.  This study highlights the importance of coordinated lipid synthesis in the formation of cellular protrusions that are essential for basement membrane invasion.

Dan M. Raben

The John Hopkins University School of Medicine, Baltimore, MD, USA

---

23 December 2024

Lipid Regulation of Adenlylyl Cyclase

Most, if not all. of us learned about the regulation of membrane-bound adenylate cyclases (often referred to as mACs) during our training and careers as scientists.Typically, we learned about the regulation of these enzymes by specific G-proteins which are themselves activated by specific membrane receptors (G-protein-coupled receptors (GPCRs)). Over time, it became clear that these enzymes are regulated by a variety of mechanisms, all of which are molecules present in the cytosol. In a recent study, Landau et al (eLife 2024;13:RP101483) have discovered the transmembrane domains of mACs respond to aliphatic lipid and anadamide to control mACs stimulated by Gsα.  The lipid signals enhance some mACs isoforms, while attenuating other isoforms. Using chimeric constructs of the various isoforms of mACs, they further showed that the hexahelical transmembrane domains of these enzymes serve as receptors for these signals. Their results open up and new, and rather novel regulatory mechanism of mACs that had been unrecognized and potentially very important.

Up to now the two hexahelical transmembrane domains of mACs were considered to fix the enzyme to membranes. Here, we show that the transmembrane domains serve in addition as signal receptors and transmitters of lipid signals that control Gsα-stimulated mAC activities. We identify aliphatic fatty acids and anandamide as receptor ligands of mAC isoforms 1–7 and 9. The ligands enhance (mAC isoforms 2, 3, 7, and 9) or attenuate (isoforms 1, 4, 5, and 6) Gsα-stimulated mAC activities in vitro and in vivo. Substitution of the stimulatory membrane receptor of mAC3 by the inhibitory receptor of mAC5 results in a ligand inhibited mAC5–mAC3 chimera. Thus, we discovered a new class of membrane receptors in which two signaling modalities are at a crossing, direct tonic lipid and indirect phasic GPCR–Gsα signaling regulating the biosynthesis of cAMP.

Dan M. Raben - The John Hopkins University School of Medicine, Baltimore, MD, USA

---

10 December 2024

The ever-evolving roles of PGE2.

PGE2 is one of the oldest known members of the prostaglandin family of oxygenated fatty acids. Originally discovered by Bergström and Samuelsson, it won them the Nobel Prize in 1982, along with Vane for discovery of how aspirin blocks cyclooxygenase.  Since then, our knowledge of its roles in both health and disease have continued to expand and nowadays it’s not only considered the pro-inflammatory cause of redness, pain and fever, but also has under several circumstances established itself as an important anti-inflammatory mediator.

Recently, another immunomodulatory function for PGE2 was revealed by Bohnacker et al in Science Immunology. Here, they focused on identification of how helminths, important intestinal parasites particularly in low-income countries, evade host immunity. Using a mouse model, they found that a worm enzyme glutamate dehydrogenase drives chronicity by suppressing macrophage functions. Here, the enzyme was already known to suppress allergic inflammation in asthma, but how it regulated immune evasion of helminths wasn’t known. 

An unusual mechanism was revealed, specifically the enzyme appears to become internalized into macrophages, where it regulates the TCA cycle and amino acid metabolism. Having said that, the authors point out that it’s not currently clear if internalization of the protein is required for this function or how it’s taken up by macrophages. Next, they showed that its non-catalytic N terminus upregulates expression of PGE2 synthetic enzymes including COX2, mPGES-1, and others.The PGE2 then suppresses alternative macrophage activation which allows the worm to evade immune clearance.  Although not discussed in this paper, since it was acknowledged that this specific worm does not infect humans, should this mechanism operate in human worm infection also, simple treatments targeting PGE2 and its signalling could be envisaged. 

Valerie O'Donnell, Cardiff University

---

25 November 2024

PLD3 and PLD4 synthesize S,S-BMP, a key phospholipid enabling lipid degradation in lysosomes

Phospholipase D (PLD), first cloned from castor beans, is a family of six known isoforms.  PLD1 and PLD2, the most widely studied isoforms of the mammalian PLDs, are catalytically active in catalyzing the hydrolysis of its principal substrate phosphatidylcholine to phosphatidic acid and free choline.  PLD3 and PLD4 are transmembrane proteins in the endoplasmic reticulum with no known catalytic activity but thought to have non-enzymatic functions in the ER.  In a recent excellent study by Singh et al (Cell 187, 1–15, November 27, 2024) the authors present data showing PLD3 and PLD4 synthesize an intraluminal lysosomal lipid, bis(monoacylglycero)phosphate vis the transphosphatidylation of lyso-phosphatidylglycerol, with the unusual stereochemical configuration where both glycerol carbons are in the S configuration (S,S-BMP). This prevents this lipid from being degraded by lysosomal phospholipases.Interestingly, loss of PLD3 and PLD4 not only leads to the absence of S,S-BMP synthesis, it leads to the accumulation of gangliosides and other lysosomal abnormalities. The authors suggest that S,S-BMP mediates the degradation of gangliosides. As PLD3 and PLD4 are exonucleases, the authors suggest that PLD3 and PLD4, like mitochondrial PLD6, may act as both lipases and exonucleases. This study has opened up some interesting and potentially important aspects of PLD research.

Daniel M. Raben - The John Hopkins University School of Medicine, Baltimore, MD, USA

---

11 November 2024

The impact of viral infection on the lipidome continues to be a topic of high interest to researchers. Of course, it’s long been known that enveloped viruses in particular hijack the host lipidome in order to generate sufficient membrane to support replication. What’s been less clear is how this is achieved, in particular what specific genes are required and how this impacts the lipidomes of the host cells.

This week, focusing on several orthoflavivirus strains, Herner et al demonstrate that glycerophospholipid (PL) remodelling is essential for replication in vitro (Glycerophospholipid remodeling is critical for orthoflavivirus infection). Early changes included increased TAG and CE, as well as lysoPL, while PL such as PE, PS and PC were all reduced. Next, the study made use of BioPAN, a tool released by LIPID MAPS a number of years ago that uses lipidomics to suggest genes that maybe responsible for changes in lipid levels in a cellular or tissue system (BioPAN: a web-based tool to explore mammalian lipidome metabolic pathways on LIPID MAPS). Highlighting the complexity of predicting gene changes using lipidomics, an area that’s still in its infancy, it’s important to remember that tools such as these don’t account for post-translational modifications so while they may predict which enzyme activity is up or down, this doesn’t necessarily mean the change is at the transcriptional level (versus changes in substrate supply, enzyme phosphorylation or other mechanisms for activating enzymes like calcium signalling).  In gene transcription data from the host cells didn’t (apart from PLA2G4C) match those predicted in silico.  Taking this into account, the mechanisms for the changes in PL levels need further exploration, since simple changes in gene expression don’t seem to provide a clear answer.

Next, the new study found that genetic deletion of various enzymes involved in the biosynthesis of phosphatidylserine and phosphatidylinositol reduce virus replication while blockade of ceramide biosynthesis had variable effects on titre levels and cell death depending on which enzyme was deleted.  These new data reveal several gene targets that are directly anti-viral, and although the study focused on orthoflaviviruses, which include Zika, West Nile, dengue and yellow fever, these findings maybe also relevant for respiratory enveloped viruses such as influenza and SARS/MERS viruses.  

Valerie O'Donnell, Cardiff University

---

28 October 2024

Inhibition of PSS1 promotes LDL uptake via increase in LDL receptors

In mammalian cells, the synthesis of phosphatidylserine (PS) is catalyzed by two calcium-dependent, apparently mitochondrially membrane associated, PS synthases (PSS). These enzymes catalyze the exchange of serine with the choline head group of phosphatidylcholine (PC), designated PSS1, or the ethanolamine head group of phosphatidylethanolamine, designated PSS2.  While there is evidence suggesting some functional redundancies between PSS1 and PSS2, gain-of-function mutations in the gene coding for PSS1 lead to aberrant increased PS production in the endoplasmic reticulum (ER) which is believed to be involved in the pathogenesis of Lenz-Majewski syndrome (LMS).  These mutations have also been shown to alter the metabolism of membrane lipids including the transport of cholesterol out of the ER. A recent report by Long et al. examines the cryo-EM structures of wild-type human PSS1 (PSS1^WT), the LMS-causing Pro269Ser mutant (PSS1^P269S), and PSS1^WT in complex with its inhibitor DS55980254.  Interestingly, these structures suggest a mechanism of PSS1 that is related to the postulated mechanisms of the membrane-bound O-acyltransferases.  Importantly, the data indicates that both PS and DS55980254 allosterically inhibit PSS1 and that inhibition by DS55980254 activates the SREBP pathways enhancing the expression of LDL receptors leading to increased cellular LDL uptake.  Overall, these data propose a mechanism of mammalian PS synthases and suggest that selective PSS1 inhibitors could lead to lower blood cholesterol levels.

Daniel M. Raben - The John Hopkins University School of Medicine, Baltimore, MD, USA

---

14 October 2024

This week’s blog is about the recent plasma ceramide ring trial, led by Federico Torta, Markus Wenk and others from the Singapore Lipidomics Incubator.  My own lab was fortunate enough to be one of the 34 participating groups and the full report of this trial was this month reported in Nature Communications: Torta et al, Concordant inter-laboratory derived concentrations of ceramides in human plasma reference materials via authentic standards. 

So, why is a ceramide plasma ring trial an important endeavor? As it stands, not many lipid categories are routinely measured in diagnostic laboratories using mass spectrometry. Partly this is down to the specialist nature and relative high cost of lipidomics, but also the fact that there needs to be a clearly defined clinical utility for the assay.  In the case of ceramides, interest in measuring these lipids has evolved over the last 20-30 years, since Yusuf Hannun and colleagues discovered their role in cancer cell death, along with characterization of their numerous and diverse structures. More recently, it was found and then replicated widely, that certain ceramides could predict risk of a vascular event. This observation led to a test being developed and licensed for cardiovascular risk clinically although as yet, this test isn’t widely adopted for testing risk in patients and it’s not yet fully established if (or how) altering ceramides will reduce event incidence.  A comprehensive news item by Mitch Leslie published last year in Science summarizes all this in more detail: Straight from the Heart.

So, considering all this, a ring trial for ceramides seems to have come along at the right time. As Torta and colleagues wrote “The main goals … were to: (i) evaluate the degree of accuracy and concordance obtained in a large inter-laboratory trial using the same shared samples and custom-tailored calibrant materials; (ii) highlight technical issues contributing to variability and technical outliers to avoid in future; (iii) document as precisely as possible the absolute concentrations of four circulating lipids in a publicly available standard reference material and (iv) lay the foundation for determination of MS-based lipidomic RI in diverse human populations across the world in a standardized fashion.”  

Importantly, not all labs used the same assay. Some used their own established methods and others, like ours, set up the Singapore SOP, which was already well standardized, and all analyzed the same plasma reference material. In summary, the study defined analytical variability and made several recommendations around use of shared reference material and authentic labelled standards, pushing the clinical analysis of ceramides one step further to routine use for cardiovascular risk testing in humans.    

Valerie O'Donnell, Cardiff University

---

30 September 2024

Etomoxir Appears to Lack Assumed Specificity

In full disclosure, I’m posting an article published by a colleague, but I believe it is worth informing the community of lipid scientists of this finding. The article, titled “Etomoxir repurposed as a promiscuous fatty acid mimetic chemoproteomic probe” (Choi et al, iScience Volume 27, Issue 9, 20 September 2024) focuses on assessing the specificity of drug often used to inhibit carnitine palmitoyltransferase I, Cpt1, in order to block mitochondrial fatty acid β-oxidation.  The authors probed the specificity of etomoxir by using click enabled etomoxir probes.  While the click-etomoxir retained its inIn hibitory effect on fatty acid oxidation, it labeled numerous proteins in cells in vitro and in vivo. Many of the identified proteins were involved in the transport and metabolism of fatty acids in the cytoplasm, peroxisome, and mitochondria. Interestingly, by using promiscuous, covalent, and fatty acid mimetic properties of etomoxir, etomoxir targets of fatty acid ω-oxidation were revealed following the loss of the peroxisomal protein Pex5. The study clearly demonstrates that etomoxir is not specific for Cpt1 as previously asserted and shows that much care should be employed when using this tool to distinguish the biological effects of fatty acid oxidation.

Daniel M. Raben

The John Hopkins University School of Medicine, Baltimore, MD, USA

---

16 September 2024

Last week was a busy one for LIPID MAPS when we hosted around 40 visitors from around the world for our business meeting at Cardiff, covering nomenclature, classification, software, tools, resources and education. The last time we had an in person meeting was 2019 at Babraham, following which we were interrupted by the pandemic. The meeting hosted a diverse group, which included lipid biochemists, analytical chemists, databasing and informatics experts, members of our strategic advisory board, and collaborative partners. We focused on reviewing our work over the last number of years, scoping out new projects and networking. 

As part of presenting on the background, I found a slide from 2019 which showed where the field of lipid research was 5 yrs ago. Issues considered important at that time included the changing demographic of lipid researchers from biochemistry to larger scale lipidomics, including the emergence of untargeted profiling and its associated annotation challenges, the need for high quality targeted methods for clinical applications, emerging technologies that might be on the horizon and challenges in supporting systems biology of lipids.  So where are we now?

Training and support for researchers, including provision of workshops and guidelines has been a big focus for many of us, including International Lipidomics Society, EpiLipidNET and LIPID MAPS, and this continues. A major guideline and associated checklist was published by ILS (ILS Journal). Relating to targeted methods, several ring trials were published, including the most recent by Torta et al on ceramides which is in press in Nat Comms. The biggest jump in MS technologies occurred in the area of enhanced fragmentation, for example, UV photodissociation, oxone-induced dissociation or other methods which allow lipids to be analysed using LC, then fragmented bond by bond to allow assignment of double bond and Sn positions. This is going to lead to the identification of many new lipids which will need to be curated. Here is an example from Michael et al. Challenges supporting systems integration of data are still very present and were a topic of active discussion, and related to that, the use of AI for several aspects of our work at LIPID MAPS was briefly covered.  

Many new ideas for supporting lipidomics came from the meeting and now the challenge will be in deciding which to prioritise and also, how to fund them through grant applications and new partnerships. 

Valerie O’Donnell

Cardiff University

---

6 September 2024

High expression of oleoyl-ACP hydrolase underpins life-threatening respiratory viral diseases

It is well known that lipids play an important role in respiratory physiology (think surfactant). A recent study by Jia et al has added another lipid, oleic acid, in the replication of influenza virus and severity of disease (Jia et al). The investigators examined patients hospitalized with avian A(H7N9) influenza to identify early drivers of fatal disease. In a transcriptomics study they found that oleoyl-acyl-carrier-protein (ACP) hydrolase (OLAH), an enzyme mediating the release of oleic acid from the oleyl-acyl-carrier protein, was strongly linked to fatal A(H7N9) disease. Interestingly, high OLAH levels were correlated with life-threatening seasonal influenza, COVID-19, respiratory syncytial virus (RSV), and multisystem inflammatory syndrome in children (MIS-C).  Using OLAH knockout (olah^-/-) mice, a lethal dose of influenza virus led to survival and mild disease as well as reduced lung viral loads, tissue damage, infection-driven pulmonary cell infiltration, and inflammation.  The investigators further showed that the inhibition of lipid droplet formation led to reduced viral infection in macrophages and supplementation of oleic acid increased influenza virus infection in macrophages and inflammation.  The authors suggest these data provide mechanistic insights into how the expression of OLAH drives life-threatening respiratory disease.

Daniel M. Raben

The John Hopkins University School of Medicine, Baltimore, MD, USA

---

22 August 2024

Keep the Tooth Fairy at bay… lipids and tooth decay

While it may be world tooth fairy day, tooth loss or a visit due to tooth decay may not be something you want to encourage.

The negative links between oral health and lipid profile shows another reason to brush your teeth. A nationwide cohort study, on Oral health and changes in lipid profile, in Korea, was carried out. Their finding suggest a strong link between tooth disease/loss and an individuals lipid profile being poor. It was shown that “that periodontitis and tooth loss are associated with decreased HDL cholesterol levels and increased triglyceride levels”. In contrast, the group where frequent tooth brushing (≥3 per day) occurred, there was a reduction in tooth decay/loss, it was implied, that this in turn lead to an increase in HDL cholesterol levels and decrease triglyceride levels. However, it is not stated whether the differences in lipid profile within these two groups were observed as the cause or effect, i.e. is tooth decay/loss dependant on an individual’s lipid profile or does tooth decay/loss lead to the alterations in lipid profile.

Are lipids the cause or the solution?

While there is only limited evidence for the benefits of the use of lipid to reduce tooth decay, this is what a paper by Kensche et al., Lipids in preventive dentistry propose . They suggest, that by adding hydrophobic characteristics to the tooth surfaces, in oil form, it could reduce damaging bacterial colonization and ultimately decrease the tooth susceptibility to disease. They also suggested that the use of lipids could allow the teeth to become more resistant to acid exposure and thus reduce erosion of the enamel, again protecting the teeth.

Their conclusions was that “edible oils” may be used as a preventative measure to stop erosion, and periodontal diseases.

---

19 August 2024

To those of us unfamiliar with the biochemistry of amphibians, the sterol compounds bufadienolides have a very unusual structure. They are bile acid-like compounds but the regular five-carbon side-chain is cyclised into a lactone containing two carbon-carbon double bonds to give a pyran-2-one ring. Bufadienolides are secreted by toads to provide a defence mechanism against predators and parasites.

In a recent paper Chen and colleagues (J. Agric. Food Chem. 2024, 72, 17377−17391) describe the isolation and structural determination of a series of bufadienolides esterified to fatty acids at C-3 of the steroid A-ring from fertilised toad eggs. Chen et al used classical liquid extraction and column methods to isolate these molecules and a combination of spectroscopic methods for structural determination. Some of the conjugates have significant biological activities. Compounds with an aldehyde group at C-19 and β-hydroxyl groups at C-5 and C-14 having potent and broad spectrum antiproliferative effects. This work extends the diversity of bile acid derivatives and adds to the list of biological properties of this family of molecules.

Bill Griffiths

Swansea University

---

6 August 2024

Membrane Localization of Proteins And Rates of Cellular Signaling

Those of us interested in membrane biology and biochemistry often wonder about the efficiency of protein-protein interactions at the membrane interface. It has been suggested that the localization of proteins to this interface will increase intermolecular association rates. This is often met with skepticism as it has been widely believed this association would be slower at the membrane than those rates in the cytosol. This question is important as many signaling events depend on the translocation of essential components which then must associate with other translocated proteins or membrane resident proteins. In a recent paper, Huang et al (Proc. Natl. Acad. Sci. Mar 5;121(10), 2024) addressed this directly by comparing the binding of complementary DNA strands, in solution and on supported membranes. Surprisingly, they discovered that rate constants within a 10µm radius spherical cell the association is 22-33-fold faster at the membrane than in the cytoplasm. They also point out, however, that this kinetic advantage depends on cell size and is essentially negligible for typical ~1µm prokaryotic cells. It seems, therefore, that while the rate constants are significantly affected at typical prokaryotic cell membranes, they are not slower either. The rate enhancement observed in smaller regions is believed to be attributable to both higher encounter rates at the membrane and an increase in reaction probability per encounter. This may be important when considering interaction and reaction rates when proteins are targeted to specific, and restricted membrane regions.

Daniel M. Raben,

The John Hopkins University School of Medicine, Baltimore, MD, USA

---

28 July 2024

Hepatitis and lipids 

28 July is World Hepatitis Day – 'The date of 28 July was chosen because it is the birthday of Nobel-prize winning scientist Dr Baruch Blumberg, who discovered hepatitis B virus (HBV) and developed a diagnostic test and vaccine for the virus' (WHO). Affecting over ~350million people worldwide, mainly in Asia, Hepatitis B virus (HBV) poses a major public health problem. While HBV vaccines and effective antiviral drugs have been available, up to 90% of HBV-infected infants and children, and around 5% of HBV-infected adults develop chronic HBV infection (1).

Hepatitis B virus (HBV) and it’s effects on lipid metabolism may be unknown, however a recent review by Zhang et al. suggested “potential targets to inhibit HBV replication or expression by decreasing or enhancing certain lipid metabolism-related proteins or metabolites”. By altering both lipid synthesis and lipolysis, HBV stimulates many changes in hepatic lipid metabolism. Given these changes, the article suggests that targeting certain lipid metabolism pathways could be a potential therapeutic way to chronic hepatitis B. While further studies are needed this review could begin to solve this crisis. 

---

9 July 2024

Aquaporin-0 Array Formation and Lipid Rafts?

There is a wealth of biological membranes that have received considerable attention from membrane biologists and biochemists.  Understanding the composition and biophysical properties of membranes leads to insights regarding their impacts on membrane proteins as well as membrane biochemistry and functions.  While we are learning a lot about the membranes that surround a variety of mammalian cells and their internal organelles, much less attention has been given to the membrane that encapsulates the ocular lens (lens membranes).  There are two interesting properties of lens membranes.  First, they contain a high percentage of sphingomyelin and cholesterol.  Second, the major protein in these membranes is a specific water channel designated as aquaporin-0 (AQP0).  Interestingly, AQP0 tetramers form large 2D square arrays (crystals) but the mechanism underlying the formation of this structure has not received much attention.  A recent paper by Chiu et al (https://elifesciences.org/reviewed-preprints/90851) has addressed this issue.  In this manuscript the authors present electron crystallographic structures of AQP0 in sphingomyelin/cholesterol membranes and used molecular dynamics (MD) simulations to identify some interesting properties.  The MD simulations show cholesterol positions represent those seen around an isolated AQP0 tetramer and that the AQP0 tetramer largely defines the location and orientation of most of its associated cholesterol molecules. The authors suggest that the properties that drive AQP0 array formation could also be responsible for protein clustering in lipid rafts opening up new insights into protein-lipid interactions and functions in membranes.

Daniel M. Raben,

The John Hopkins University School of Medicine, Baltimore, MD, USA

---

24 June 2024

Last week, it was a pleasure to be part of a review panel for the German Research funding organisation Deutsche Forschungsgemeinschaft (DFG).  The programme we reviewed fell under the Priority Programmes (SPP) area and is called “Ferroptosis: from Molecular Basics to Clinical Applications”.  Like all SPP programmes, it runs for 6 years, being split into two 3 year periods, and this time, researchers across Germany were competing for the second tranche of project specific funding. This to hosted within a consortium (led by Marcus Conrad at Helmholz Zentrum München) that focuses on excellent research, collaboration, training and networking with a strong ethos of equality.  Two enjoyable days were spent hearing about the seminal discoveries made by the consortium, and the proposed follow on and new work, that covers diverse applications including cancer, neurodegeneration, and underpinning mechanisms. 

Ferroptosis is the relatively recent name given to cell death dependent on iron and lipid peroxidation.  While the premise that redox cycling by metals in concert with lipid hydroperoxides (or hydrogen peroxide, aka Fenton chemistry) can cause cell death has been around for decades, it’s only been in recent years that a specific name was assigned to it. The free radical theory of ageing was originally proposed by Denham Harman in the 1950s.  Here Fenton chemistry was proposed to be causative in inflammation, cardiovascular disease, neurodegeneration, cancer and ageing. This led to many theories about how antioxidants could prevent disease and increase longevity.  This was strongly advocated by Linus Pauling in the 1970s, who used theoretical arguments to (inaccurately) claim that extremely high doses of Vitamin C would help us “live longer and feel better”.  However, this wasn’t to be and slowly, research moved on, and the free radical theory of ageing fell by the wayside around 2014. 

Notwithstanding the history of the field, oxidative damage involving lipids and iron causes significant levels of tissue damage and cell death, and preventing this, or activating it selectively remains to be exploited therapeutically. Key to this is a more in depth understanding of the mechanisms involved.  Assigning the iron/lipid peroxidation-dependent cell death process a name is transforming research on this topic.  In particular, recent seminal work by many groups has unveiled new protein players or endogenous small molecules which either promote or prevent ferroptosis in mammalian cells, while other studies investigate the potential role of harnessing this pathway, e.g. in cancer therapy.  This new knowledge is revealing important new paradigms, as one example the recent elucidation of a role for PGE2 in regulating IL2 signaling and mitochondrial function, recently published in Nature by the SPP consortium.

A challenge for the field remains in drug development and clinical applications.  Antioxidants and metal chelators were up to now the only choice available, however they did not in the past translate to effective therapies. However, with the advent of many new protein targets, discovered in this new wave of research, that situation may to strongly poised to change.  The second tranche of the DFG SPP programme will be very interesting to watch in this regard.  

Valerie O’Donnell, Cardiff University.

---

14 June 2024

How blood donation can alter the lipid profile

Not only can giving blood save the life countless others, research suggests it may also improve YOUR OWN health!!!

World Blood Donor Day a World Health Organization campaign has been celebrated on the 14th of June for the last 20 years and seeks to inform and encourage new blood donation globally. 

In this short blog I explore the health benefit claims that regular blood donation can decrease the ‘bad lipids’ in the blood. While there may be conflicting papers discussing the health benefits of donating bloody, which may include a reduction in heart rate, blood pressure and weight, here I look further into the lipid profile of blood and see what effects blood donation might be having. 

A paper published by EI Uche, Lipid profile of regular blood donors, concluded that donating blood regularly will contribute to a reduction in the LDL/HDL ratio. This ratio is used as an indicator, which when high, suggests an increased cardiovascular risk. Overall, this study showed “that regular blood donation is associated with lowering of serum lipids”. We can therefore conclude that, when regularly donating blood, there is a reduction in the LDL/HDL ratio, which could reduce the risk of developing heart disease. 

More recent studies have also concluded the same, in a paper by Kebalo AH, Lipid and Haematologic Profiling of Regular Blood Donors Revealed Health Benefits, it was suggested that regular blood donations “has a significant health benefit by lowering TC, TG and LDL-c”. When elevated, these have the potential risk of contributing to the development of chronic inflammation, therefore any reduction could decrease this overall risk.

This proposed reduction, when regularly donating blood, in cholesterol and triglyceride levels, often associated with heart disease and stroke, should certainly encourage anyone who doesn’t already donate blood to get signed up!

---

10 June 2024

Essential Role for the C-terminal Domain of Oleate Hydratase

Microorganisms are known for having unique and interesting enzymes.  One class of such unique enzymes that are particularly interesting are the fatty acid hydratases.  Oleate hydratase (OhyA) is a flavoprotein which catalyzes the hydroxylation of oleic acid to 10-(R)-hydroxy stearic acid (10-HSA).  The structure and mechanism of OhyA from Staphylococcus aureus was first described in 2021 in Chuck Rock’s laboratory at St. Jude’s Research Hospital (J Biol Chem.2021;296:100252).  As an oleate hydratase, OhyA must access its substrate which is embedded in membrane bilayers.  Therefore, this enzyme must be able to extract the fatty acid from the membrane and encapsulate it within its active site.  In a recent report by Radka et al, the Rock lab provided data illuminating the critical role of the carboxy terminus in assembling the enzyme on a bilayer.  They showed that the positively charged helix-turn-helix motif in the carboxy terminus (CTD) interacts with negatively charged phosphatidylglycerol (PG) in the bilayer. They showed that the CTD region is sufficient for membrane association with nanomolar affinity.  Interestingly, the authors showed that while the CTD binds the PG surface, it does not insert into the bilayer.  Overall, their data show that the binding of OhyA CTD to a PG surface is essential for obtaining bilayer-embedded unsaturated fatty acids.  As a side note, this article was especially difficult to write as Chuck suddenly passed away last September.  His kindness, intelligence, humanity and contributions to science will be sorely missed.  

Daniel M. Raben,

The John Hopkins University School of Medicine, Baltimore, MD, USA

---

28 May 2024

Multiple Sclerosis and what lipids have the power to achieve

Ahead of World Multiple Sclerosis (MS) Day on 30th of May, my blog covers the possible role of lipids in MS diagnosis and treatment. 

MS is one of the most common diseases of the central nervous system (CNS). It is estimated around 3 people around the world have MS, with 300 being diagnosed every day.  This disease has a complex pathogenesis, which includes two main processes: immune-mediated inflammatory demyelination and progressive neurodegeneration with axonal loss. Lipids may play a crucial role in underlying immunopathogenesis of MS.

A review on ‘New Insights into Multiple Sclerosis Mechanisms’ highlights key features of lipids in this field. A key component in axonal myelin sheaths are lipids, therefore it is logical for them to play a central role in disease progression; both in inflammatory demyelination and progressive neurodegeneration. Research suggests that lipids may also be a useful diagnosis tool, when lipid biomarkers are considered. Lipidomics could also be considered when monitoring disease progression, such as lipid analysis which could demonstrate specific biomarkers for MS. At present new drugs are being designed in which lipids are both targets of treatment and carriers of novel therapeutics (see my previous blog on lipid nanoparticles). 

The review concludes that sphingolipids, phospholipids, glycerolipids, and sterols are worth further investigation in their role in MS, leading to better future diagnosis and treatment. 

Lauren Cockayne, Cardiff University

---

13 May 2024

Optogenetics and Lipid Imaging Highlights the Role of Lipids In Neural Plasticity

Perhaps one of the most recognized lipid metabolizing enzymes involved in regulating membrane involved signaling and dynamics are the phospholipases C (PLCs). This has inspired numerous studies to examine the precise role of these enzymes in various physiologically important membrane processes.  These studies, however, are often limited in resolution by our inability to precisely examine the localization of these enzymes and their resulting lipid metabolism.  Recently Kim et al (Cell Chem. Biol. 31: 1-13, 2024) have taken advantage of optogenetics to examine the spatiotemporal dynamics of PLCβ membrane localization and activation on membrane lipid metabolism and neurophysiology.  These investigators used an opto-PLCβ that uses a light-induced dimer module, to direct the enzyme to the plasma membrane in a light-dependent manner.  Using phospholipase D (PLD) and diacylglycerol (DAG) kinase inhibitors, they provided evidence that a PLD contributes to DAG clearance in the membrane.  Further, the authors show that the opto-PLCβ enhances amygdala synaptic plasticity and associative fear learning in mice.  This study shows the power of using optogenetic approaches to examine the biological and physiological impacts of induced membrane lipid metabolism.

Daniel M. Raben,

The John Hopkins University School of Medicine, Baltimore, MD, USA

---

30 April 2024

Today, I came across an interesting paper on new lipid scramblases published in the current issue of PNAS, but there was a paywall, and unusually, no institutional access.  It seems that only 27 UK Higher Education institutions have access to PNAS, with many Russell Group institutions (Cambridge, Manchester, Bristol, Glasgow, Birmingham) missing off the list.  However, the authors had last year deposited a preprint on BioRxiv, which is free and not for profit, so, that’s the version I’m blogging about this week (Paper: Lipid scrambling is a general feature of protein insertases).   I’d encourage everyone to use BioRxiv, MedRxiv or other preprint servers so that not only those of us in academia can read papers, but everyone can.

This new study, from Li et al in Yale and Switzerland claims that protein insertases, which are well known to translocate peptides across membranes, also act as lipid scramblases in the ER and mitochondria.   Phospholipids are generated in the ER, but only on the cytosolic side, and so to allow for membrane expansion, they need to be equilibrated by “scramblases”, which move them between both leaflets.  Up to now, only a small number of scramblases were known, and these tend to be mainly in the plasma membrane, such as those involved in apoptosis or platelet activation which work on PE and PS mainly.  However, which scramblases were involved in membrane biogenesis was totally unknown. 

In this study, Li et al postulated that a group of proteins called protein insertases could be involved, since they had similar structural features, notably a hydrophobic channel and ability to locally thin membranes.  To test this, they used liposomes which contained lipids labelled with nitrobenzoxadiazole, which allowed them to bind to BSA, but only if they were on the outer leaflet.  This led to fluorescence changes indicative of internal or external localisation.  They then reconstituted several proteins into the liposomes to determine which could scramble the membranes. Most of the tested proteins had scrambling activity, with only two showing none.  This was followed by molecular dynamics simulation studies which was validated using proteins either with or without scrambling activity.  Overall, the MDS was able to reproduce the in vitro scrambling activity.  

This interesting work revealed several new candidate lipid scramblases, but what is missing are studies in cells to validate in vitro and in silico findings.  The authors consider that this will be almost impossible since these proteins have other critical functions in cells.  It would be interesting to consider how to overcome this issue and truly reveal whether protein insertases are indeed also lipid scramblases in cells and in vivo.

Valerie O'Donnell, Cardiff University

---

24 April 2024

Lipids in the world of immunization – the role of lipid nanoparticles in mRNA vaccines

Keeping my blogs topical and in line with current global events, as it is World Immunization Week I thought I would write about the relevance of lipids in vaccines.

While mRNA nor indeed the idea of mRNA vaccines is not new, the approval and use of lipid nanoparticles (LNPs) for the delivery of mRNA vaccines is innovate and exciting (1).   LNPs hit the headlines when the COVID-19 mRNA vaccine was approved for use in December 2020. The mRNA vaccines, produced by Pfizer and BioNTech, quickly followed by Moderna were the first mRNA vaccines authorized for clinical use. 

The Nature review  “Lasting impact of lipid nanoparticles”, delves further into the background, that demonstrates that without lipid nanoparticles, the mRNA COVID-19 vaccine would not have been possible. In essence, LNPs, which are generally made up of four different lipids, comprising cationic or ionizable lipids, phospholipids, cholesterol and polyethylene glycol functionalized lipids (PEG-lipids) (1), provide a protective ‘wrapper’ to transport and deliver the mRNA into cells. Crazy to think how these lipids have transformed drug delivery!!

Find out more about World Immunization Week on the WHO webpage. 

Lauren Cockayne 

Cardiff University 

---

15 April 2024

Lipids Tune Membrane Mechanical Properties for Fusion

Membrane fusion is a common occurrence in a wide variety of biological processes.  There have been studies showing particular lipid and their relative compositions in membranes can have profound effects on the fusing potential of membranes.  Indeed, studies have pointed to the fact that the inner leaflet of the plasma membrane is more fusogenic than the outer leaflet.  In a fascinating recent study by Lira et al (J. Biol. Chem 299(2); 105430, 2023) the authors use the fusion of large unilamellar vesicles and giant unilamellar vesicles and a combination of confocal microscopy and time-resolved imaging to uncover the mechanical membrane properties that regulate membrane fusion.  Their data show how lipids affect membrane mechanics that modulate membrane fusion and the resulting post-fusion stability.  Interestingly, their data suggest that cholesterol somewhat reduces fusion efficiency and pore formation, it also has an indirect role in establishing a competent environment for fusion proteins.

Daniel M. Raben,

The John Hopkins University School of Medicine, Baltimore, MD, USA

---

2 April 2024

High quality software is essential for both analysing and then managing the massive lipidomics datasets that are generated from today’s mass spectrometry experiments. One salient example is where fragmentation of every single detected molecule is undertaken, followed by “identification” of as many lipids as possible, using databases containing information about putative product ions. 

Considering we simply don’t have MS/MS data on every single molecule in every category, reference libraries based on in silico data are increasingly applied to identification of both knowns and unknowns. Up to know, strategies to generate these libraries mainly included rule-based and combinatorial fragmentation approaches. However, these don’t take into account gas phase chemistry that occurs during collision induced dissociation, and more recent attempts to generate better prediction including quantum-chemical computation are being developed.

In the meantime, where does that leave us in relation to trustworthiness of identifications obtained using existing libraries?  To test this out, Tetering and Oomens conducted a spectroscopic test, and on the basis of their findings, suggest that fragment ion structure annotation in MS/MS libraries are “frequently incorrect” (van Tetering, L., Spies, S., Wildeman, Q.D.K. et al, 2024).   Here, they used infrared ion spectroscopy to characterise individual product ions and compare them with those proposed by HMDB, METLIN and mzCloud. In some cases, the structure wasn’t correct while in others, the proposed structure needed a proton to be added to get the right m/z value.  What this means is that the proposed structures of the product ions aren’t the same as those actually being formed. 

So what can the lipidomics field take from this… first, the tested precursors weren’t lipids, they were amino acids and other small molecules.  Many lipids (e.g. glycerides, phospholipids, etc) follow very predictable routes to fragmentation, such as loss of ketene, carboxylate anion, headgroup, etc), and so we don’t expect to find many problems there.  However, it was interesting that some of the differences occur due to the formation of cyclic structures during fragmentation and we would expect to see such behaviour for many other lipids, such as oxylipins, or maybe also sterols.

Although the actual annotation of the fragment doesn’t form part of the spectral comparisons, it’s still important to ensure the information is correct since use of incorrect assumptions may lead to generation of additional in silico spectra that will contain significant errors.

Val O'Donnell, Cardiff University.

---

25 March 2024

Lipids in Neurodiversity

As part of the Neurodiversity Celebration Week, I had a brief look into how lipids may be altered in those with an Autism Spectrum Disorder (ASD) and how lipidomics could affect a diagnosis. 

The Centers for Disease Control and Prevention US (CDC) define ASD as a “developmental disability caused by differences in the brain. People with ASD often have problems with social communication and interaction, and restricted or repetitive behaviors or interests.” There are currently no conclusive tests that can be carried out to determine ASD such as a blood or urine analysis, and diagnosis is a long and subjective process, dependent on clinical expertise. 

Various studies have suggested a contribution of altered lipid signaling and/or metabolism to the pathogenesis of ASD. A paper by Afaf El-Ansary et al. goes one step further than suggesting possible causes by depicting The Role of Lipidomics in Autism Spectrum Disorder. Here they propose that a defined set of metabolites may be useful to diagnose ASD via lipidomics. It is possible therefore that measuring lipid biomarkers may provide a novel approach to improve diagnosis for ASD.

Lauren Cockayne 

Cardiff University

---

18 March 2024

New Role for Phosphoinostides: Modulation of Lysosomal Function in Response to Nutrient Status

Phosphoinositides, and their metabolism, have long been recognized as the archetype of signaling lipids.  In fact, the list of phosphoinositide-involved signaling pathways is quite impressive.  This is indeed a well-deserved reputation given the number of signaling pathways that involve these lipids.  It almost appears their roles have been exhausted but a recent report highlights yet more physiological roles for these lipids.  A recent report (Ebner et al.Cell, 2023 Nov 22; 186(24): 5328-5346) demonstrates a role for these lipids modulate activities in lysosomes that bear on the anabolic as well as catabolic functions of this organelle in response to cellular nutrient status.  The authors provide evidence that lysosome morphology and function are reversibly controlled by a nutrient-regulated signaling switch in phosphoinositide localization that modulates mTORC1.  The authors show the nutrient-dependent conversion between peripheral motile mTORC1 signaling-active and static mTORC1-inactive degradative lysosomes clustered at the cell center.  It appears that starvation triggers the relocalization of phosphatidylinositol 4-phosphate (PI(4)P)-metabolizing enzymes which reshapes the lysosomal surface proteome facilitating lysosomal proteolysis and repression of mTORC1 signaling. Additionally, lysosomal phosphatidylinositol 3-phosphate (PI(3)P), associated with motile signaling-active lysosomes in the cell periphery, is eliminated.  Important, interfering with this PI(3)P/PI(4)P lipid switch impairs the adaptive response of cells to nutrients.  These data add yet another role for phosphoinositides by showing that they play an important role in signaling a shift if cellular nutrient statues via the alteration of lysosomal membrane dynamics.

Daniel M. Raben,

The Johns Hopkins University School of Medicine, Baltimore, MD, USA

---

4 March 2024

New lipids from old samples

The most widely used ionization method in LC/MS/MS, electrospray, is considered a rather “soft ionization” mode, meaning it provides limited fragmentation information for lipids, when compared with the older methods that were available on gas chromatography, such as electron impact ionization.  This has meant that detailed structural information on double bond position was not generated during fragmentation of molecules when using electrospray, and so assumptions were often made based on the most abundant fatty acyls already known to be present in the samples.  As an example, for mammalian tissues, it would be assumed that FA 20:4 was generally arachidonic acid, with its specific composition of cis double bonds at C5,8,11 and 14.   However, new MS modalities are now becoming available that, combined with LC/MS/MS can achieve fragmentation that reports on the molecular composition of lipids to a depth which was not previously possible, and these are beginning to reveal a diversity of FA in the human lipidome that goes far beyond what we thought we know.   These methods include UV-photodissociation with ozone (UVPD, or OzID), which has been implemented both on Orbitraps (Thermo) as well as ToFs, including within the ion mobility cell (Waters), and a second method called Electron activated dissociation, available on Sciex ToF instruments. The application of these approaches to lipidomics is somewhat still in its infancy and it’s going to be really interesting to see the impact of this on our understanding of the molecular diversity of lipids in general.  A recent study on this from the Blanksby group revealed unexpected diversity of lipidomes from plasma, cell lines and vernix caseosa (Nature Article).  The study increased the number of plasma FA by two-fold, including finding non-methylene interrupted FA structures, and added over 90 new FA to LMSD.  How these many new FA and the complex lipids they will undoubtedly be attached to, contribute to lipid biology and biochemistry in health and disease is going to be a matter for exciting research in the coming years.

Valerie O'Donnell, Cardiff University

---

16 February 2024

Complex Sphingolipids Lipid Rafts Modulate Lipid Domains and Microlipophagy

During nutrient limitation a process known as microlipophage is induced where lipid droplets are hydrolyzed by lysosomes, or vacuoles in yeast (Saccharomyces cerevisiae).  It has been shown that cells lacking the ability to generate phase separated domains in these vacuoles are defective in macrolipophagy.  In a recent report Kim and Budin (J. Biol. Chem. 300 (1): 105496 (2024)) present some intriguing data indicating that the generation of complex sphingolipids and sorting into yeast vacuoles is key to membrane lipid phase separations in these vacuoles which modulate micro-lipophagy.  The role of these sphingolipids was examined via a systematic genetic dissection of the biosynthetic pathway of these lipids. Their data show that the abundance of complex sphingolipids determined the extent of domain formation which was associated micro-lipophagy.  Their results are the first to indicate that the trafficking of the complex sphingolipids drive membrane phase separations that impact micro-lipophagy in yeast.

Daniel M. Raben,

The Johns Hopkins University School of Medicine, Baltimore, MD, USA

---

5 February 2024

The formation of a presynaptic site in a neuron requires transport of specific proteins from the soma (where the nucleus is housed) along the axon to the axon terminal.  There’s a lot not known about this process, for example, the biochemistry of the vesicles that carry the presynaptic proteins is not yet clear, nor where they originate from.  In Rizalar et al an essential role for a lipid signalling pathway in this process was recently demonstrated.   Using fluorescent labelling, chemical dimerization, and focused ion beam milling scanning electron microscopy (FIB-SEM), they showed that phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) signalling supports the transport of synaptic vesicles and their active zone proteins along the axon, guiding them to the presynaptic site located in precursor vesicles. Importantly, they also determined the ultrastructure and size of the vesicles.  PI(3,5)P2 is already known to be involved in inherited neurodegeneration, so elucidating a role in the context of axon biology extends our knowledge of how this specialised lipid is involved in brain health, thus also paving the way for improving our understanding of its role in neurological disorders.  A perspective on the article has also been published.

Valerie O'Donnell, Cardiff University

---

23 January 2024

Complex Sphingolipids Lipid Rafts Modulate Lipid Domains and Microlipophagy

During nutrient limitation a process known as microlipophage is induced where lipid droplets are hydrolyzed by lysosomes, or vacuoles in yeast (Saccharomyces cerevisiae).  It has been shown that cells lacking the ability to generate phase separated domains in these vacuoles are defective in macrolipophagy.  In a recent report Kim and Budin (J. Biol. Chem. 300 (1): 105496 (2024)) present some intriguing data indicating that the generation of complex sphingolipids and sorting into yeast vacuoles is key to membrane lipid phase separations in these vacuoles which modulate micro-lipophagy.  The role of these sphingolipids was examined via a systematic genetic dissection of the biosynthetic pathway of these lipids. Their data show that the abundance of complex sphingolipids determined the extent of domain formation which was associated micro-lipophagy.  Their results are the first to indicate that the trafficking of the complex sphingolipids drive membrane phase separations that impact micro-lipophagy in yeast.

Daniel M. Raben,

The Johns Hopkins University School of Medicine, Baltimore, MD, USA

---

8 January 2024

Reading about how predators use a diversity of strategies to target prey led us to a paper published last year in Science Advances by Lee et al, from Taipei, focused on how a carnivorous mushroom uses a volatile ketone lipid to paralyze and kill nematodes (https://www.science.org/doi/10.1126/sciadv.ade4809). In this interesting study, the authors used a genetic approach generating 12K random mutants of the oyster mushroom (P. ostreatus) and then tested these to identify processes for killing of C. elegans.  First, they found that the toxic mutants contained a spherical structure on their hypae, called toxocysts, and showed these were essential for paralysis of the prey.  Next, they determined the molecular composition of toxocysts using GC/MS with spectral library matching, and found that a single compound, 3-octanone, characterised these structures. Following this, in elegant studies, they then showed that 3-octanone could trigger paralysis, calcium influx and cell necrosis in the nematode, as well as disrupting cell membrane integrity and causing death.   Intriguingly, when looking at the chemical properties required for toxicity, the position of the ketone was less important than the total carbon number of the compound.  This study greatly extends our knowledge about the biology of eight-carbon volatile organic compounds in fungal biology, where they were already well known as communication signals.   Importantly, the detailed mechanisms by which these compounds act is not fully clear, but in this case, it appears that the compound inserts itself into membranes causing biophysical changes that lead to its toxic actions.  In this regard, it may be considered analogous to other toxins which disrupt membranes, such as phospholipases or bacterial pore forming toxins.  The paper proposes that this new mechanism could be useful for developing the fungus as a biocontrol agent against parasitic nematodes in agriculture.   

Valerie O'Donnell, Cardiff University.

---

11 December 2023

Effect of Lipid Saturation on Nuclear Envelope Function

Since it became obvious that lipids do more than provide a platform to support membrane proteins, there has been a long-standing and growing interest among many lipid and membrane investigators regarding the role of lipids in the regulation of membrane protein function.  While most of the attention has been given to plasma membrane lipids, there has been some interest in the role of lipid residing in intracellular membranes.  Initially, much of the attention was given to the endoplasmic reticulum (ER) given its role in secretion and lipid metabolism.  In a recent article by Romanauska and Kohler (Nature Cell Biology 25:1290-1302, 2023) have provided compelling evidence that lipid acyl chain structure is linked to the structure of the double bilayer membranes that surrounds the nucleus. This double membrane is continuous with the ER.  Interestingly, their data shows that increased lipid saturation is detrimental to maintaining the homeostasis between the nuclear pore complex and the ER.  The authors argue that increases in saturated lipids leads to micron-scale lipid phase separation of the NE/ER into rigid and more elastic domains resulting in the anomalous segregation of NPCs into the elastic phase.  Importantly, the provide evidence that these phase separation makes nuclei more susceptible to rupture leading to the leakage and exposure of chromosomal DNA.  Surprisingly, lipid droplets appear to preserve the integrity of the nuclear membrane including the nuclear pore complex.  Further work on the role of lipids on the integrity and function of the nuclear envelop will certainly uncover some fundamental aspects driving the relationship between lipids and nuclear functions.

Daniel M. Raben,

The Johns Hopkins University School of Medicine, Baltimore, MD, USA

---

29 November 2023

Last week, I read with interest a new paper from Anaisa Ferreira, Martin Giera and colleagues, published in Nat Comms (https://www.nature.com/articles/s41467-023-43315-x#Sec2) , showing that BCG vaccination leads to increased levels of LOX products in monocytes of healthy individuals. Importantly, this study also showed that this increase, along with changes in long-chain PUFA biosynthesis was required for the trained immunity response of these cells.  This follows on from other seminal studies showing that LOXs in monocytes and macrophages are not only involved in innate, but also adaptive immunity, however there’s still a lot we don’t know about this and what the lipids are specifically doing in this context from a signaling point of view.  Ferreira et al showed that pharmacological inhibition of FADS2, LXR, 5- or 12-LOX all reduced trained immunity in vitro, while SNPs in desaturases and LOX genes influenced trained immunity in human volunteers.  Several mono-hydroxy oxylipins were implicated in this process.  The question then becomes what are the lipids doing?  Several years ago, Stefan Uderhardt and Gerhard Krönke showed that 12/15-LOX, which is the most likely candidate for formation of many of these lipids in monocytes, was involved in immunologic tolerance (https://www.sciencedirect.com/science/article/pii/S1074761312001288?via%3Dihub). They showed how 12/15-LOX is required for removal of apoptotic cells via a mechanism involving oxidized phospholipids acting as a specific signal on the cell surface.  Although this sounds very different to the new study, both address the role of monocytic LOX in adaptive immunity and it’s tempting to speculate on how these findings maybe related. How the mono-hydroxy oxylipins detected in Ferreira et al are acting is so far unknown, and could include direct receptor dependent signaling or their esterification into complex lipid pools, as seen in Uderhardt.  Follow on work to address these questions will be very interesting.

Valerie O'Donnell, Cardiff University.

---

13 November 2023

Sphingolipids are a major class of membrane lipids that play vital physiological roles, especially in the nervous system.  It has been long-established that gangliosides, the glycosphingolipids found in numerous membranes, serve as receptors for several bacterial toxins and viruses and interact with and modulate the function of other cellular receptors. The peptide (sequence CGSPGWVRC) binds to the surface of pulmonary primary vascular endothelial cells contributes to emphysema-like changes.  In a recent article by Staquicini et al. (Proc Natl Acad Sci U S A. 2023 Aug 22;120(34)) they have identified the receptor to be C16-ceramide.  These authors show that CGSPGWVRC activates acid sphingomyelinase and ceramide production, in the absence of apoptotic signaling, leading to the formation of ceramide-rich platforms.  Interestingly, these authors further showed that the targeting of the peptide to C16-ceramide can be used as a bioinorganic hydrogel for pulmonary imaging as well as a ligand-directed lung immunization tool against COVID-19. This study has provided evidence for yet another new role for sphingolipids.

Daniel M. Raben,

The Johns Hopkins University School of Medicine, Baltimore, MD, USA

---

30 October 2023

Two weeks ago, via the magic of Zoom, I sat in on a lab meeting at Bruce Hammock’s lab, which was being presented by Nils Schebb, over visiting from Germany.  A large part of his talk concerned an under-researched but very interesting area…. The occurrence of oxylipins in food.  Those of us working biomedical applications of oxylipins generally think only of them as being produced endogenously. We don’t consider how we might be exposed to them through other routes, and food, especially that containing fats that have undergone some oxidation (heat, age, etc) or express lipoxygenases and other PUFA oxidizing enzymes, are an obvious potential source.  Nils focused in two recent papers, Koch et al, available here (10.1021/acs.jafc.2c04987, 10.1021/acs.jafc.3c02724) on the occurrence of C18 oxFA in flaxseed, sunflower and rapeseed oil.  He and his team identified a large number of new mono-OH lipids derived from linoleic (LA) or a-linolenic (ALA) acids, and present in higher abundance than the most often studied 9- and 13- species from either LA or ALA.  In several oils, they were present at up to 0.1% of the oil content, which is pretty significant.  We have to wonder what they might be doing there and how this might impact human health.

The work raises many new and interesting questions. Oxylipins generated enzymatically and non-enzymatically don’t only include mono-hydroxy-FA, they also include truncated reactive aldehyde species, and for PUFA with more double bonds, others with complex PG-like ring structures may also form, so what else is there? Analysis was carried out after hydrolysis to remove FA from complex lipids, so are these free oxylipins or mainly esterified to glycerides or phospholipids? Considering that refined oil consists of >99% triglycerides (fat), the oxylipins in vegetable oils should be largely bound to this species. Schebb et al also expertly used GC/MS to work out double bond position of these new lipids, so it will also be interesting to see how new LC/MS methods like UVPD might be useful in future work of this kind.

Last, what are the biological consequences once these lipids are first exposed to high acid levels in the stomach then hydrolysed to release the free oxylipins in the gut by lipases during absorption. Oxylipins have diverse biological effects, including both pro- (e.g. EP, DP, TP receptors during inflammation) and anti-inflammatory (e.g. PPARg signaling) and the likely impact of these will of course be context dependent. Much work remains to understand the implications of this work and to further our knowledge of oxylipin environmental exposure on human health.

Val O'Donnell

Cardiff University

---

17 October 2023

The biophysical properties of membranes is critically important to membrane function.  This architecture can influence a number of physiologically important functions including transport, signaling, cell recognition, fusion, and interactions with the cytoskeleton.  Such biophysical properties depend on the fluidity membranes which depends on the length and degree of unsaturated fatty acid components of constituent phospholipids.  It has been recognized that the degree of saturation in eukaryotes depends on desaturases that require molecular oxygen.  This raised an interesting question as to how certain organisms, such as Schizosaccharomyces japonicus can grow in both aerobic and anaerobic conditions.  In a recent study, Panconi et al J. Biol. Chem. (2023), use microscopic, lipidomic, and molecular dynamic approaches to show that these organisms modulate membrane fluidity, at 24⁰C, but interestingly not 37⁰C, by increasing the amount of asymmetric tail phospholipids, such as 18:0 and 10:0, allowing for increased fluidity, in response to anoxic conditions.  It is noteworthy that this was not seen in a related species of yeast, Schizosaccharomyces pombe.  This gives S. japonicus a growth advantage under anoxic conditions showing once again lipids come to the rescue!

Daniel M. Raben,

The Johns Hopkins University School of Medicine, Baltimore, MD, USA

---

10 October 2023

I was very interested to read Bill Christie’s recent blog on the challenges of dealing with big data in lipid research, which is nowadays exemplified by the application of informatics approaches to lipidomics.  It’s inspired me to add my own thoughts, relating to the task of assessing and ensuring data quality at the level of raw data.  The launch of new software is often accompanied by claims of its superiority in relation to existing tools.  However, it’s not till the community have time to evaluate software, that we can agree on how robust, accurate and reliable a tool really is and this can take time. Software is increasingly being asked to “adjudicate” on whether a lipid is present in a sample based on appearance of chromatographic and MS/MS data.  In the past, this was performed by visual/manual inspection which when done correctly, works very well. However, when we move to large datasets, we often need to use software to automate and increase throughput.  Great care is needed with this because computers only do as good a job as they are programmed to do, and they don’t replace common sense.  Different software tools will use distinct algorithms for the “same” job, and comparing their outputs can show wildly different results. How can we deal with this?  We have to exercise caution by sanity checking our data using our own eyes, especially where we are analysing low abundance lipids.  Understanding how a tool works “under the bonnet” is also important. Algorithms making spurious claims from raw MS data isn’t a new problem as those familiar with the story about proteomics MS in ovarian cancer biomarkers may remember.  If you haven’t heard of this, check out this study from 20 years ago, which showed that processing noise had allowed cancer patients to be distinguished from controls, using SELDI-ToF MS: https://academic.oup.com/bioinformatics/article/20/5/777/214156?login=false.  

Val O'Donnell

Cardiff University

---

26 September 2023

DIESL: A New DGAT Regulated by TMX1 for the Synthesis of TAGs in Mammalian Cells

A paradigm in metabolism is the recognition that triacylglycerols (TAGs) represent a major source of stored energy in a variety of organisms from bacteria to humans.  TAGs are composed of three fatty acids esterified to the three carbons of glycerol.  There is great interest in these neutral lipids as their synthesis and metabolism play roles in a variety of physiological and pathophysiological processes.  It has been long recognized that TAGs are synthesized via in humans by the condensation of coenzyme A-conjugated fatty acids to the carbons on glycerol  This reaction has long been recognized to be catalyzed by two diacylglycerol O-acyltransferases (DGATs): DGAT1 and DGAT2.  Interestingly, other organisms possess additional enzymes for the generation of TAGs but has not been clear whether alternative pathways also exist in humans.

In a recent report by McLelland et al Nature 621:171–178 (2023) and see review by Schaffer, JC in Nature 621:47-48 (2023) has solved this mystery by identifying a novel pathway for the synthesis of TAGs in mammalian cells.  The authors performed a loss of function CRISPR screen using haploid human cells in which both DGAT1 and DGAT2 had been knocked out. In this screen, they discovered that the elimination of a transmembrane thioredoxin (TMX1) led to an increase in TAG synthesis.  As TMX1 does not catalyze the synthesis of TAGs the authors screened for genes that led to a decrease in TAG synthesis when disrupted in the haploid cells also lacking TMX1. They identified a protein they called DAG1/2-independent enzyme synthesizing storage lipids (DIESL).  Further analyses identified DIESL as another DGAT but one that is inhibited by TMX1.  Interestingly, DIESL appears to use phospholipids, or phospholipid precursors, as a source of TAG fatty acids.  This is an exciting discovery and future work to uncover the regulation and roles of this enzyme is sure to lead to other important discoveries.

Daniel M. Raben,

The Johns Hopkins University School of Medicine, Baltimore, MD, USA

---

11 September 2023

As I have mentioned on several occasions, I feel that I have missed out in never having had access to modern mass spectrometry methods for analysis of intact lipids. However, I am sure that I am not alone in finding the vast amount of data that is now produced completely indigestible. I know that moves are underway to improve comparisons of data between labs, but as an independent observer I find that I can use very little of what I read in my web pages other than general conclusions. For example, in comparing lipid compositions from different species, organelles, etc, I have tabulated data from publications that are more than 50 years old, simply because I can find little comparable that is more recent.

I have just been reading an excellent review on lipidomics information, but in 27 pages and 260 references, there are no tables of compositional data or even graphical illustrations (Sarmento, M.J. et al. The expanding organelle lipidomes: current knowledge and challenges. Cell. Mol. Life Sci., 80, 237 (2023); DOI). This is not a criticism of the authors, as I understand the problem – there are simply far too many data points from each lipid in every study, especially when positional distributions in glycerolipids are taken into account. I would like to see a table in each publication (or in the supplemental information) in which the data are simplified by aggregating molecular species to give the total amount for each lipid class. Then, within each lipid class, molecular species should be tabulate as the total, saturated, monoenes, dienes, etc. Finally, the fatty acid positional distributions (and/or totals) within each glycerolipid class should be determined by aggregating the results for each molecular species. It should not be a major task to devise a computer programme to do this.

I am not advocating that the individual data points are ignored, and data must continue to be expressed as at present. My suggestion is for an additional way to present the information – not an alternative. My concern is for the external observer, who wants the big picture as well as the minutiae.

Bill Christie

The LipidWeb, Dundee, Scotland

---

5 September 2023

Last week, I attended the annual meeting of the International Lipidomics Society (ILS) in Vienna. A key part of harmonization and standardization within lipidomics is the correct lipid identification and quantification by mass spectrometry. To support this, ILS is now developing minimal lipid analysis guidelines, which will describe how to properly identify and quantify lipids from raw mass spectrometry signals.  The focus will be on low abundant lipids such as oxylipins, that includes octadecanoids, eicosanoids (e.g., prostaglandins, leukotrienes, thromboxanes) and docosanoids as well as oxygenation products of n3 and n6 fatty acids termed specialized pro-resolving mediators.

I’m delighted to serve as the Chair of the new Interest Group on Oxylipin Analysis Guidelines that the International Lipidomics Society have set up. I’m grateful especially to Kim Ekroos and Gerhard Liebisch for productive and positive discussions on this topic, and for those who have agreed to act as our initial core group to set out the principles under which we will operate. These are: Makoto Arita (Riken, Japan), Craig Wheelock (Karolinska Institute, Sweden), Nils Schebb (Uni Wuppertal, Germany), Hubert Vesper (Centre for Disease Control and Prevention, USA) and Miguel Gijon (Cayman Chemical, USA). Once a plan is in place, the Interest Group will be opened up and all who are interested can join us to be part of guideline development. We encourage you to get involved by joining us on zoom and developing a published guideline.

Valerie O'Donnell

Cardiff University

---

18 August 2023

Interesting Chemistry Underlying the Synthesis of GDGT in Archaea

Understanding the chemistry of lipid metabolizing enzymes is often challenging, but insights can be fascinating. Take, for example, the synthesis of isoprenoid-based ether-linked membrane lipids in Archaea.  These lipids are important because they enable these organisms to withstand extreme environmental conditions. In some archaea, like Methanocaldococcus jannaschii, it has been shown that these lipids may form macrocyclic diether lipids or macrocyclic glycerol dibiphytanyl glycerol tetraethers (GDGT). Interestingly, GDGT is a membrane-spanning lipid that contains covalent bonds between the terminal carbons of the inner and outer leaflets of the membrane, providing enhanced membrane stability. While the mechanism underlying the formation of these unique lipids was obscure for many decades, work from Squire Booker’s laboratory at The Pennsylvania State University has elucidated it (Lloyd et al. Nature. 2022 Sep;609(7925):197-203 DOI). The reaction is unique in that it involves coupling two inert sp³-hybridized carbon centers. In vitro mechanistic studies indicate that C(sp³)–C(sp³) bond formation occurs on fully saturated archaeal lipid substrates and proceeds through an intermediate containing a bond between the substrate carbon and a sulfur ion of an auxiliary [Fe₄S₄] cluster to stabilize a transient carbon-centered radical. This work finalizes the biosynthetic route for GDGT formation and reveals the first instance of C(sp³)–C(sp³) coupling in nature.

Dr. Squire Booker
Evan Pugh University Professor of Chemistry and of Biochemistry and Molecular Biology
Pennsylvania State University
Eberly College of Science
Department of Chemistry

Mr. Cody Lloyd
Pennsylvania State University
Eberly College of Science
Department of Chemistry

---

7 August 2023

A few weeks ago, Matt Conroy and I had the pleasure of attending the Annual EpilipidNET meeting hosted by Justine Bertrand-Michel in Toulouse, France (https://www.epilipid.net/).  This was the penultimate annual meeting of this pan-European EU COST Network, led by Maria Fedorova and Rosario Domingues, which has over the last 3 years brought together over 390 researchers from 47 countries, far beyond Europe, to facilitate a huge range of lipidomics activities.  Huge credit is due to the leadership of EpilipidNET, for driving this initiative, which has transformed the profile of lipid research in Europe in a very short time, bringing together interest groups across diverse remits including:  Plant and Algal Lipidomics, Lipidomes of Common Model Organisms, Bacterial Lipidomes and Subcellular Lipidomics.  All these areas are of direct relevance to LIPID MAPS, since provision of data on structures, reactions pathways and lipid metadata and making this information freely available to the community is a common goal of both initiatives.  

 

If you are a young (or not so young) researcher, either experienced or new to the field, be sure to check out EpilipidNETs activities.  The last annual meeting will be in Dresden in 2024, but before this, there are several other meetings and workshops including a hackathon on curation of model organisms lipidomes.  All events and activities are free of charge to attend, and bursaries are often available too.

Valerie O'Donnell,

School of Medicine, Cardiff University, UK

 

---

24 July 2023

A family of proteins referred to as the ORMs/ORMDLs serve as regulatory subunits of the rate-liming enzyme in the synthesis of sphingolipids, serine palmitoyltransferase (SPT) complex.  This complex is known to be homeostatically regulated by cellular sphingolipid levels, but how cells sense these levels has been a matter of controversy.  This controversy seems to now be resolved.  In a recent article by Xie et al (Nat. Commun. 2023, Jun 13;14(1) 3475;  DOI) the authors show that purified human SPT-ORMDL complexes are directly inhibited by ceramide.  This was accomplished by solving the cryo-EM structure of the SPT-ORMDL3 complex in a ceramide-bound state, demonstrating a specific ceramide-binding site within the complex.  Furthermore, structure-guided mutational analyses demonstrated that this ceramide binding induces and locks the N-terminus of ORMDL3 into an inhibitory conformation. Interestingly, the authors note that childhood amyotrophic lateral sclerosis (ALS) variants in the SPTLC1 subunit cause impaired ceramide sensing in the SPT-ORMDL3 mutants.  This exciting work reveals the molecular basis of ceramide sensing by SPT-ORMDL as well as the functional consequences of this interaction and suggests an important role of impaired ceramide sensing in disease.

Daniel M. Raben,

The Johns Hopkins University School of Medicine, Baltimore, MD, USA

---

7 June 2023

There have been numerous studies focused on the generation and metabolism of lipid droplets. Despite these studies, our understanding of how these droplets develop from the endoplasmic reticulum (ER) has been incomplete. For example, triacylglycerol and cholesterol esters are two of the most abundant neutral lipids in these structures but they are very different molecules with very different physical properties. This is highlighted by the fact that triacylglycerols melt at -4°C while cholesterol esters melt at a much lower temperature of -44°C. A recent article from Abdou Rachid Thiam’s laboratory, and in collaboration with Ilp Vattulainen and Elina Ikonen, data are presented that indicate cholesterol esters can form supercooled lipid droplets in the presence of triacylglycerols (Nat. Commun., 14, 915 (2023);  DOI). These authors demonstrate that cholesterol esters form supercooled lipid droplets above 20 mol% with respect to triacylglycerol levels, and liquid-crystalline phases when the level increases to above 90 mol% at 37°C. They further show that at physiological temperatures, seipin-mediated triacylglycerol clusters catalyze the nucleation of cholesterol esters in the ER bilayer to initiate the formation of lipid droplets. Their data are particularly interesting given, as suggested by their melting temperatures, cholesterol esters would be expected to form a crystalline phase at physiological temperatures, but in the presence of triacylglycerols these lipids are condensed into nascent lipid droplets. Their data not only provides insights into the formation of lipid droplets, it suggests how macrophages generate cholesterol ester-rich lipid droplets leading to foam cells, as well as how spatially distinct other lipid droplets can form for other physiological processes such as steroid hormone synthesis.

Daniel M. Raben,
The Johns Hopkins University School of Medicine, Baltimore, MD, USA

---

24 May 2023

Each animal cell can contain up to 1000 distinct molecular species, with each lipid class containing multiple combinations of the fatty acid components. It seems likely that a high proportion of these are simply present to provide the correct blend of physical properties required for the structural function of a lipid in membranes, but it is surprising how many individual molecular forms have been recognized as having unique biological roles within tissues. One good example of this is 1-palmitoyl-2-oleoyl-phosphatidyl-sn-glycerol of lung surfactant, which attenuates inflammation by antagonizing the cognate ligand activation of the toll-like receptors (TLR2/1, TLR3, TLR4, and TLR2/6), while it disrupts the binding of virus particles to the plasma membrane receptors required for viral uptake in host cells, including influenza and SARS-CoV-2 viruses (Numata, M. et al. The anti-inflammatory and antiviral properties of anionic pulmonary surfactant phospholipids. Immun. Rev., in press (2023);  DOI).

It has been recognised for some time that the 18:0-18:1 species of phosphatidylserine has a distinctive role in membranes probably through physical interaction with sphingolipids (Skotland, T. and Sandvig, K. The role of PS 18:0/18:1 in membrane function. Nature Commun., 10, 2752 (2019);  DOI). More surprising is a recent publication demonstrating that a bacterial species from human gut, produces a phosphatidylethanolamine species with two different branched chain components (anteiso-15:0 and iso-15:0) that has remarkable specificity for immune signalling in its host via a toll-like receptor TLR2-TLR1 heterodimer; no other combination of acyl groups works (Bae, M. et al. Akkermansia muciniphila phospholipid induces homeostatic immune responses. Nature, 608, 168-173 (2022);  DOI).

Bill Christie

The LipidWeb, Dundee, Scotland

---

17 May 2023

Some biochemical terms can have needlessly complex or obscure meanings, so it is always pleasing to find terms that are immediately understandable and useful, such as ‘flippases’ and ‘scramblases’ for proteins that mediate the movement of phospholipids between the leaflets of membrane bilayers. Flippases direct phosphatidylethanolamine and phosphatidylserine to the cytoplasmic leaflet (floppases work in the opposite direction), while scramblases as the name suggests randomly scramble phospholipids between leaflets across the membrane and collapse the membrane asymmetry. In particular, the latter can transfer phosphatidylserine to the outer leaflet where its exposure on the cell surface is an ‘eat-me’ signal to macrophages, another memorable term (we Scots would call them ‘couthy’). A new review on the topic is worth a read (Sakuragi, T. and Nagata, S. Regulation of phospholipid distribution in the lipid bilayer by flippases and scramblases. Nature Rev. Mol. Cell Biol., in press (2023);  DOI).

Pick up any newspaper and you will see that artificial intelligence (AI) is giving concern for any number of reasons. I understand that one such programme passed a US bar exam with flying colours, and universities world-wide are concerned with their use to cheat in essays. There are also worries that they are being used to create bogus scientific publications, and I have seen so many review articles on ferroptosis especially lately – I will say no more! There are several commercial programmes available that purport to improve the standard of written English - a worthy objective, and I am sure that they could be of legitimate value especially for those who have difficulty with the language. Are they too open to abuse?

Bill Christie,
The LipidWeb, Dundee, Scotland

---